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Abstract 
 Regulation of the processing of genes into nucleic acids and proteins is a 
substantial goal in medicine.  Small molecules that could enter cells, localize to the 
nucleus, and bind chromosomal DNA sequence-specifically and with high affinity would 
be important tools for gene regulation.  Pyrrole-imidazole polyamides are small 
molecules that bind the minor groove of DNA in a sequence-specific fashion according to 
a set of pairing rules, and with affinities rivaling natural transcription factors.  Several in 
vitro experiments have shown that by directly competing with transcription factors for 
binding sites in gene promoter regions, polyamides can act to inhibit transcription of 
those genes.  Polyamides bearing transcription activation domains can bind to promoter 
regions, recruit the transcriptional machinery to the gene, and activate transcription in 
vitro.  Attempts to reproduce these results in vivo were largely unsuccessful, perhaps due 
to poor cellular trafficking properties of polyamides and polyamide-peptide conjugates. 
 It was found that polyamides bearing the Bodipy fluorophore localize primarily to 
the cytoplasm of cells, or were excluded from cells altogether.  In attempts to overcome 
this quality, peptides shown to improve cellular trafficking were appended to the 
polyamides.  These peptides were generally not successful at inducing uptake, and were 
in many cases toxic to the cells.  Small molecules were also appended to polyamides, 
likewise to improve uptake properties, but met with limited success.  Surprisingly, the 
addition of a fluorescein or fluorescein-like fluorophore to polyamides permit them to 
localize to the nuclei of all cell lines tested, in a molecular content- and shape-dependent 
manner.  This technology has been applied to several in vivo experiments, including the 
inhibition of androgen receptor binding to its cognate element in gene promoter regions. 
 vii
Table of Contents 
Page 
Acknowledgements……………………………………………………………………….iv 
Abstract………………………………………………………………………………...…vi 
Table of Contents……………………………………………………………………...…vii 
List of Figures and Tables………………………………………………………………..ix 
 
Chapter 1 Introduction to DNA Recognition by Minor Groove-Binding 
  Polyamides………………………………………………………..……….1 
 
Chapter 2 Transcription Activation with Polyamide-Polyproline-Peptide 
  Conjugates…………………………………………………..……………24 
 
Chapter 3 Polyamide-Peptide and Polyamide-Small Molecule Conjugates  
for Cellular Uptake Studies………………………………………………43 
 
3A Polyamide-Peptide Conjugates for Cellular Uptake Studies…………….44 
 
3B Polyamide-Small Molecule Conjugates for Cellular Uptake 
Studies……………………………………………………………..……..65 
 
Chapter 4 Nuclear Uptake of Polyamide-Fluorophore Conjugates in 
Mammalian Cell Lines…………………………………………………...84 
 viii
4A Polyamide-FITC Conjugates for Cellular Uptake Studies……………….85 
 
4B Influence of Structural Variation on Nuclear Localization of 
DNA-Binding Polyamide-Fluorophore Conjugates…….……………...106 
 
4C DNA-Binding Characteristics of Polyamide-Fluorophore  
Conjugates………………………………………………………………145 
 
Chapter 5 Inhibition of Transcription on the Androgen Response Element 
with Polyamides and Polyamide Conjugates…………………………...155
 ix
List of Figures and Tables 
Chapter 1                          Page 
Figure 1.1 DNA base pairs………………………………………………………...….3 
Figure 1.2 Structural features of the DNA double helix…………………………...…4 
Figure 1.3 X-ray crystal structures of DNA recognition by proteins……………...….5 
Figure 1.4 X-ray crystal structures of minor groove-binding small molecules……....7 
Figure 1.5 Minor groove recognition by polyamides………………………….…..….9 
Figure 1.6 Hydrogen-bonding model of the hairpin motif…………………………..10 
Figure 1.7 Other covalently-linked polyamide motifs………………………………12 
Figure 1.8 Hairpin polyamides as transcriptional inhibitors………………………...14 
Figure 1.9 Hairpin polyamides as transcriptional activators………………………...15 
Figure 1.10 X-ray crystal structure of a hairpin polyamide bound to the  
nucleosome core particle…………………………………………………16 
Figure 1.11 Cellular uptake of a fluorescent polyamide……………………………...17 
 
Chapter 2 
Figure 2.1 Activation of gene transcription by artificial transcription factors………27 
Figure 2.2 Poly-L-proline-based molecular rulers…………………………………...28 
Figure 2.3 Structures of polyamide-activation peptide conjugates………………….28 
Figure 2.4 Synthesis of polyamide-peptide conjugates……………………………...29 
Figure 2.5 In vitro transcription reactions with polyamide-polyproline-peptide 
  conjugates………………………………………………………………..30 
 x
Figure 2.6 Summary of four independent in vitro transcription reactions 
showing the relative potency of each compound in comparison 
to PAPro6-AD……………………………………………………………31 
Figure 2.7 Quantitative DNase I footprinting titration of polyamide- 
polyproline-peptide conjugates…………………………………………..32 
Figure 2.8 Synthesis of polyproline-dye conjugates………………………………...34 
Figure 2.9 FRET data for polyproline helices……………………………………….35 
 
Table 2.1 Summary of equilibrium dissociation constants for polyamide- 
  polyproline-peptide conjugates…………………………………………..33 
 
Chapter 3 
Figure 3.1 Localization of polyamide–Bodipy conjugates in live cells……………..46 
Figure 3.2 Confocal microscopy illustrates cellular localization of a  
polyamide-Bodipy conjugate in live human cell lines……………..…….47 
Figure 3.3 Localization of peptide-polyamide–Bodipy conjugates in live  
Cells as determined by confocal microscopy………...…………………..49 
Figure 3.4 DNA-binding characteristics of tail-linked polyamide-peptide 
conjugates……………………………………………………………..…50 
Figure 3.5 Localization of N-methyl-linked peptide-polyamide–Bodipy 
conjugates………………………………………………………………..52 
Figure 3.6 DNA-binding characteristics of N-methyl-linked polyamide- 
peptide conjugates……………………………………………………….53 
 xi
Figure 3.7 Effect of molecular shape on uptake and DNA-binding properties……...54 
Figure 3.8 N-terminal imidazole-linked peptide-polyamide-Bodipy 
conjugates for nuclear uptake studies……………………………………55 
Figure 3.9 Synthesis of a representative compound in the N-terminal-linked 
series……………………………………………………………………..56 
Figure 3.10 Localization of the N-terminal-linked series in live cells………………..57 
Figure 3.11 N-terminal imidazole-linked polyamide-peptide conjugates 
for footprinting studies…………………………………………………...59 
Figure 3.12 DNA-binding characteristics of N-terminal imidazole-linked 
polyamide-peptide conjugates…………………………………………...60 
Figure 3.13 Disulfide-linked polyamide-peptide prodrugs…………………………...62 
Figure 3.14 Synthesis of disulfide conjugates………………………………………...64 
Figure 3.15 Bodipy-polyamide-chlorambucil conjugates for cell uptake studies…….66 
Figure 3.16 Bodipy-polyamide-small molecule conjugates for cell uptake studies…..67 
Figure 3.17 Synthesis of CHL conjugates…………………………………………….69 
Figure 3.18 Synthesis of DHT conjugate……………………………………………..70 
 
Chapter 4 
Figure 4.1 Structures of compounds used in uptake experiments…………………...89 
Figure 4.2 Cellular localization of polyamide-fluorescein conjugates………………90 
Figure 4.3 Uptake profile of polyamide-fluorescein conjugates in 13 
  mammalian cell lines…………………………………………………….91 
 xii
Figure 4.4 Quantitative DNase I footprinting titration of polyamide- 
  fluorescein conjugates…………………………………………………...92 
Figure 4.5 Energy dependence of nuclear localization of a polyamide- 
  fluorescein conjugate…………………………………………………….94 
Figure 4.6 Conjugates to test the effect of dye composition on cellular 
  localization……………………………………………………………...110 
Figure 4.7 Uptake profile of dye composition compounds………………………...111 
Figure 4.8 Conjugates to test the effect of next generation rings on cellular 
  localization…………………………………………………………...…114 
Figure 4.9 Uptake profile of next generation ring compounds…………………….115 
Figure 4.10 Conjugates to test the effect of extended hairpins on cellular 
  localization……………………………………………………….…..…117 
Figure 4.11 Uptake profile of extended hairpin compounds…………..…….………118 
Figure 4.12 Conjugates to test the effect of increasing size on cellular 
  localization…………………………………………………………...…119 
Figure 4.13 Uptake profile of large hairpin compounds…………………………….120 
Figure 4.14 Conjugates to test the effect of β-alanine tails on cellular 
  localization…………………………………………………………...…122 
Figure 4.15 Uptake profile of β-alanine tail compounds………………………...….123 
Figure 4.16 Conjugates to test the effect of the H2Nγ-turn on cellular 
localization……………………………………………………………...125 
Figure 4.17 Uptake profile of compounds possessing the H2Nγ-turn ………………..126 
 xiii
Figure 4.18 Conjugates to test the effect of other polyamide motifs on cellular 
localization……………………………………………………………...127 
Figure 4.19 Uptake profile of compounds based on other polyamide motifs…….....128 
Figure 4.20 Conjugates to test the effect of addition of short peptides on 
  cellular localization……………………………………….…………….130 
Figure 4.21 Synthetic scheme for short peptide-polyamide-FITC conjugates………131 
Figure 4.22 Uptake profile of short peptide-polyamide-FITC conjugates………..…132 
Figure 4.23 Chemical structures of tail-linked polyamide-FITC conjugates 
  for DNase I footprinting………………………….…….……………….146 
Figure 4.24 Fooprinting gels for compounds 1-3……………………………………147 
Figure 4.25 Fooprinting gels for compounds 4-6……………………………………149 
Figure 4.26 Chemical structures of polyamide-fluorophore conjugates with 
  alternate motifs………………………………………………………….150 
Figure 4.27 Footprinting gels of alternate motif polyamide-fluorophore 
Compounds……………………………………………………………..151 
 
Table 4.1 Mass spectra of hairpin polyamide-FITC conjugates…………………..103 
Table 4.2 Mass spectra of large panel of polyamide-fluorophore conjugates…….139 
Table 4.3 Binding characteristics of polyamide-FITC conjugates compared 
to their parent polyamides………………………………...…………….148 
Table 4.4 Comparison of the binding characteristics of alternate motifs for 
polyamide-FITC conjugates…………………………………………….152 
 xiv
Chapter 5 
Figure 5.1 X-ray crystal structure of androgen receptor binding DNA…………....158 
Figure 5.2 Polyamides for AR-ARE inhibition…………………………………….159 
Figure 5.3 DNase I footprinting of polyamides for AR-ARE inhibition….……….160 
Figure 5.4 In vitro transcription assay of AR-ARE inhibition polyamides………...161 
Figure 5.5 Polyamide-DHT conjugates for AR-ARE inhibition………………...…163 
Figure 5.6 Synthetic scheme for polyamide-DHT conjugates…………………..…164 
Figure 5.7 Mechanism of androgen-mediated AR activation……………………...165  
Figure 5.8 DNA-binding and transcription inhibition with DHT conjugates……...166 
Figure 5.9 Polyamide-FITC conjugates for AR inhibition…………………………168 
 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
Introduction to DNA Recognition by Minor Groove-Binding Polyamides 
 2
Background and Significance 
 DNA is the medium of information storage by which content from the large-scale 
combinatorial experiment of evolution has been stored and refined over time.1  This 
information is retained in lengths of discrete linear polymers of deoxyribonucleic acids, 
or genes, which serve as instructions for the synthesis of an organism’s complement of 
ribonucleic acids and proteins.  Faithful reading, duplication, and utilization of genetic 
material are the essential steps by which living organisms are created, grow, and 
multiply.  This privileged placement at the root of all processes necessary to the 
maintenance and propagation of life highlights DNA as an attractive target for a plethora 
of diagnostic and therapeutic applications.  The recently completed initiative to record the 
complete human genome provides a wealth of knowledge necessary to take advantage of 
DNA as a target in human medicine.  This achievement provides a blueprint for the 
ground floor of living systems.  The human genome describes more than 30,000 putative 
genes, each a possible therapeutic or diagnostic target, or a subject of basic biochemical 
research.2,3  Illumination of the organizational parameters of the genome, the diversity of 
individual variation in genetic sequence, and the dynamics of genetic processing are 
among the next growing points of biochemical research.  The means by which these 
central questions will be pursued are diverse; among them are molecules designed to bind 
predetermined DNA sequences and provide some analyzable effect.  Minor groove- 
binding polyamides, programmed to strongly and selectively bind desired DNA 
sequences, are powerful tools that may be leveraged in a multitude of diagnostic and 
therapeutic applications.4 
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Structural Features of DNA 
 Genomic material is composed of two complementary, antiparallel 
polydeoxyribonucleotide strands intertwined in a double helical structure.  The strands 
are associated by specific hydrogen bonding interactions between the nucleotide bases, 
adenine pairing with thymine and guanine pairing with cytosine (Figure 1.1).5  The sugar 
phosphate backbones of the paired strands define helical grooves, in whose floors the 
edges of the heterocyclic bases are exposed (Figure 1.2).  The biologically relevant B-
form of the DNA double helix is characterized by a wide and shallow major groove, and 
Figure 1.1  DNA base pairs.  (a) The chemical structure of the A·T and G·C DNA 
base pairs.  (b) Space-filling models, based on crystal structure data, for the A·T and 
C·C base pairs, aligned in an analogous fashion to the chemical structures.  “T” base is 
in blue, “A” base is in yellow, “G” base is in green, and “C” base is in wheat. 
Nitrogen atoms at interface are in marine and oxygen atoms at interface are in red.  (c) 
View of the A·T and G·C base pairs looking down into the minor groove, colored as in 
(b).7 
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a narrow and deep minor groove.6  The molecular surfaces and chemical features 
presented by a given DNA sequence, though essentially identical to first order, at the 
atomic scale are distinct.  This differentiation provides a basis for the sequence-selective 
recognition of DNA by proteins and small molecules. 
 
DNA Recognition Strategies in Natural Systems 
 Evolution has resulted in the employment of a diverse selection of structural 
motifs by proteins recognizing DNA.  Combinations of electrostatic interactions with the 
negatively-charged sugar phosphate backbone and van der Waals interactions with the 
nucleobases in the floor of the helical grooves provide both the affinity and specificity by 
which proteins bind DNA (Figure 1.3).8-12  Specific interactions of proteins with DNA  
Figure 1.2  Structural features of the DNA double helix.  The phosphate backbone of 
the DNA is in slate, and the nucleic acid bases are in grey.  The major and minor 
grooves are outlined.7 
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Figure 1.3  X-ray crystal structures of DNA recognition by proteins.  (a) GCN4 
recognizes DNA through homodimeric recognition of the major groove.  (b) Zinc 
finger Zif268 through recognition of the major groove.  (c) TBP recognizes DNA 
primarily through minor groove contacts, causing a severe bend to the DNA helix. 
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often require multiple proteins, or multiple copies of the same protein, to achieve the 
programmed effect.  These interactions are dynamically rich phenomena, often 
proceeding through structural shifting of either or both the protein components and the 
DNA helix. 
 A majority of DNA-binding proteins rely on major groove contacts to provide 
sequence specificity, though a few, such as TATA-binding protein, utilize minor groove 
contacts.  The engineering of proteins with novel DNA-binding properties is an ongoing 
effort in biochemical research.  There have been some successes using phage display 
techniques to select zinc finger proteins that bind predetermined sequences.  However, 
attempts to modify the DNA-binding qualities of these proteins in a rational manner have 
met with little success.  This has shown that, to date, there is no known general 
recognition code linking target DNA base pair sequence with protein amino acid 
sequence.13 
 Though the complexity of protein structure makes the rational design of DNA-
binding polypeptides quite challenging, other paradigms exist in nature for the 
recognition of DNA sequences.  A number of small molecules have been discovered that 
bind DNA with high affinity and with some sequence specificity.14-16  Many of these 
compounds utilize the narrow, deep minor groove as their recognition domain on the 
DNA double helix.  These natural products include calicheamicin, Hoechst 33258, 
distamycin, and the closely related netropsin (Figure 1.4).  Among these, the polypyrrole 
compounds netropsin and distamycin are particularly attractive as lead compounds due to 
their relative chemical simplicity, small size, and, most especially, their modular nature.  
The synthetic manipulation of the polypyrrole lead molecules into a sophisticated class of  
 7
Figure 1.4  X-ray crystal structures of minor-groove binding small molecules.  (a) 
Calicheamicin is an enediyne-containing oligosaccharide that upon recognition of 
sequences such as TCCT, TCTC, and TTTT, causes a double-strand cleavage.  (b) 
Hoechst 33258 recognizes A·T, T·A domains selectively.  (c) Distamycin also 
recognizes A·T, T·A tracts selectively, and may bind as either a monomer, or as 
antiparallel dimers (as shown) within the minor groove. 
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heterocyclic oligomers has led to the investigation of the static and dynamic parameters 
governing their interaction with the DNA minor groove in great detail.17 
The laboratories of Prof. Peter B. Dervan have utilized the distamycin scaffold to 
synthesize a new class of small molecules which are able to bind the minor groove of 
DNA with high affinity and specificity.4,18-20  This set of molecules is composed of N-
methylimidazole (Im), N-methylpyrrole (Py), N-methyl-3-hydroxypyrrole (Hp), 3-chloro-
thiophene-2-carboxamide (Ct), benzimidazole (Bi), and hydroxybenzimidazole (Hz) 
amino acid residues linked into crescent-shaped oligomers.  As with distamycin, 
polyamides may bind the DNA minor groove as monomeric units or as antiparallel 
dimers, in a concentration-dependent manner.  DNA association is driven by a 
combination of van der Waals interactions and specific hydrogen bonds.  Side-by-side 
pairings of aromatic residues stack the polyamide heterocyclic rings against each other 
and the walls of the minor groove, positioning the polyamide backbone and aromatic 3-
substituents to contact the edges of nucleotide bases in the minor groove floor.  This 
arrangement allows polyamides to exploit the specific pattern of hydrogen bond donors 
and acceptors present along the edges of the nucleic acid bases, as well as the subtle 
variations in molecular shape in the floor of the minor groove, to recognize and bind to 
specific Watson-Crick base pairs (Figure 1.5).21 
 Exhaustive physical studies of the interaction of minor groove-binding 
polyamides with DNA using a variety of techniques, including DNase I footprinting, X-
ray crystallography, multidimensional NMR spectroscopy, and fluorescence asssays, 
have yielded a set of guidelines.  These pairing rules dictate that specific unsymmetrical 
pairings of  Im with Hp, Hz, and Py residues, and of Ct with Py, in a cofacial 
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arrangement, underlie the binding characteristics of minor groove-binding polyamides.22  
A pairing of Im with Py (symbolized Im/Py) targets a G·C base pair, while Py/Im targets 
C·G.23  The physical basis for this specific interaction is primarily due to a linear 
hydrogen bond formed between the N3 of the Im residue and the exocyclic amine of 
guanine.24  A pairing of Py with itself (Py/Py) is degenerate for both T·A and A·T.  In 
order to specify between adenine and thymine DNA residues, either the Hp or Hz 
residues may be employed.  Hp/Py and Hz/Py target T·A, while Py/Hp and Py/Hz target 
A·T.  The selectivity of Hp is derived from both hydrogen bonding interactions with the 
thymine O2, and shape-selective recognition of the asymmetric cleft between the T·A 
Figure 1.5  Minor groove recognition by polyamides.  An X-ray crystal structure of a 
DNA helix bound by homodimeric polyamides.26  The polyamides and the DNA base 
pairs they recognize are represented in the ball-and-stick model.  A black circle 
represents Im, a white circle represents Py, a red circle containing an “H” represents 
Hp, a diamond represents β-alanine, and an arc with a “+” represents Dp.  The 
recognition of minor groove contacts in a T·A base pair by Hp/Py and the recognition 
of a G·C base pair by Im/Py are shown at right, from the same crystal structure.  DNA 
bases in the polyamide binding site are colored as in Figure 1.1. 
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versus A·T base pair.21,25,26  The selectivity of Hz is thought to be due to the same 
structural and chemical reasons, though no X-ray crystal structures or NMR structures 
have been determined thus far.27  A pairing of Ct with Py at the N-terminal cap position 
has been shown to target T·A selectively over A·T, G·C, or C·G, it is thought through 
projection of the 3-chloro substituent into the floor of the minor groove.28 
 
The Hairpin Motif 
 The ability of linear polyamides to dimerize within the DNA minor groove 
suggested the possibility of creating a covalent linkage between the antiparallel strands, 
reducing the entropic cost of association with DNA.  This hairpin motif, connecting the 
N-terminus of one polyamide strand with the C-terminus of the second strand through an 
aliphatic γ-aminobutyric acid residue (γ), provides ligands with affinities and specificities 
Figure 1.6  Hydrogen-bonding model of the hairpin motif.  (a) H-bonding and pairing 
rules for classic Im/Py/Hp polyamides.  (b) H-bonding and pairing rules for hairpin 
polyamides incorporating new aromatic residues Ct, Bi, and Hz.  Im residues are in 
bold black, Py residues are in regular black, Hp residues are in red, Bi residue is in 
violet, Hz residue is in blue, Ct residue is in yellow. 
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rivaling DNA-binding proteins.29,30  Hairpin polyamides utilize the same hydrogen 
bonding and van der Waals interactions to govern DNA binding, exhibiting the same 
orientational preference as unlinked dimers, aligning N→C with respect to the 5’→3’ 
direction of the adjacent DNA strand (Figure 1.6).31,32   
Exceptional cases have been observed in which some hairpins in some DNA 
contexts will bind in a reverse fashion, N→C with respect to the 3’→5’ direction of the 
adjacent DNA strand.  There are also examples of hairpins binding DNA in an unfolded 
conformation as a single extended strand.  Both of these issues are resolved upon 
introduction of a chiral amine moiety on the α carbon of the γ-turn residue.33  Both turn 
residues exhibit selectivity for A·T and T·A base pairs over G·C and C·G base pairs, 
presumably due to steric clashes with the guanine exocyclic amine.30,33 
Similarly, the aliphatic β-alanine (β) and N,N-dimethylaminopropylamine (Dp) 
residues often found at the C-terminal tails of polyamides are selective for A·T and T·A 
base pairs over G·C and C·G.  Though imparting additional selectivity to polyamide 
binding, the tail residues are not critical to DNA binding, and can be replaced or 
removed.34  Often, the β-alanine residue is useful as an internal residue within the 
polyamide strand, paired against either Im, Py, or other β residues.35,36  This utility arises 
due to the supercurvature of polyamide strands with reference to the curvature of the 
DNA minor groove.  Though the rise per residue of polyamides correlates closely with 
the pitch of the B-form DNA helix, beyond five consecutive aromatic residues the shape 
of the polyamide is no longer complementary to the DNA minor groove.37  Internal β-
alanine residues, which are inherently more flexible than aromatic residues, allow the 
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relaxation of the curvature of polyamide strands, allowing DNA sequences longer than 
five base pairs to be recognized effectively. 
Despite the successes of the hairpin polyamide motif, the set of sequences that the 
hairpin motif can target is limited by the T,A selectivity of the aliphatic turn moiety.  In 
order to enlarge the set of targetable DNA sequences, other polyamide motifs have been 
developed, employing a variety of strategies to covalently-link individual polyamide 
strands.  These new motifs include cycles38, H-pins39, and U-pins40 (Figure 1.7). 
Gene Regulation with Polyamides 
By utilizing the pairing rules, minor groove-binding polyamides may be 
synthesized to bind predetermined DNA sequences, including those within the promoter 
regions of genes.  Proper placement of polyamides in the promoter sequence may allow 
them to interfere with the association of transcription factors, leading to inhibition of 
transcription.  It has been demonstrated that polyamides are able to inhibit the binding of 
certain zinc finger proteins (including Zif268, Figure 1.3b) that bind DNA without any 
Cycle U-pin H-pin
5' - A  T  G  T  A  C  A - 3'
3' - T  A  C  A  T  G  T - 5'
5' - T  G  G  T  C - 3'
3' - A  C  C  A  G - 5'
5' - A  T  G  T  T  A  C  A  T - 3'
3' - T  A  C  A  A  T  G  T  A - 5'
Hairpin
5' - A  T  G  T  A  C  A - 3'
3' - T  A  C  A  T  G  T - 5'
Ka = 2.9 x 1011 M-1
Ka = 4.4 x 108 M-1 Ka = 4.3 x 1010 M-1Ka = 7.0 x 1010 M-1
Figure 1.7  Ball-and-stick schematic for covalently linked polyamide motifs.
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minor groove contacts, presumably by an allosteric mechanism.41  However, minor 
groove-binding ligands can also co-occupy DNA while certain proteins, such as GCN4 
(Figure 1.3a) occupy the major groove.42  GCN4 binding has been inhibited successfully 
by hairpin polyamides bearing “positive patches” targeting protein-phosphate 
contacts,43,44 and by polyamide-intercalator conjugates.45 
Better targets for polyamides have been minor groove-binding transcription 
factors, such as TBP (Figure 1.3c) and LEF-1.  Several transcription factors and 
promoters have been successfully targeted by hairpin polyamides, including the TFIIIA 
zinc finger46,47 and the HIV-1 promoter,48,49 resulting in inhibition of RNA polymerase II 
transcription of targeted genes in vitro (Figure 1.8). 
It is also possible to selectively activate transcription by synthesizing a 
polyamide, designed to bind in the promoter region of a gene of interest, to which has 
been appended a moiety that recruits the transcriptional machinery to the promoter 
(Figure 1.9).  Polyamides bearing a viral peptide known to activate transcription have 
been used to increase transcription of diagnostic genes more than 30-fold over basal 
levels.50-52  Since polyamides can target a wide variety of sequences with high affinity 
and specificity, this approach has great potential as a general method of gene-specific 
activation by small molecules.  Though the principle was proven, little was determined 
about the physical parameters of the DNA/polyamide/transcriptional machinery 
interaction—especially the optimal distance between the DNA and the activation domain. 
The successful use of polyamides in model systems has shown their promise as 
diagnostic and therapeutic agents in more complex environments.  For a polyamide to 
have a DNA-mediated effect in an organism, it must be able to enter the organism’s cells, 
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traffic to the nucleus, and bind chromosomal DNA.  The fundamental repeating unit of 
chromatin is the nucleosome, which consists of the nucleosome core particle (NCP) and 
20-80 base pairs of linker DNA.  The NCP is built from two superhelical turns of DNA 
(147 base pairs) wrapped around a core of eight histone proteins to form a disc-shaped 
tightly-packed unit. 
Figure 1.8  Hairpin polyamides have successfully inhibited the binding of several 
proteins to DNA in solution.  Transcription factor binding sites are shaded. 
HIV-1 Promoter  
5'-G A G C T G C A T C C G G A G T A C T A C A A A G A C-3'
3'-C T C G A C G T A G G C C T C A T G A T G T T T C T G-5'
Xenopus tRNA Promoter Scanning (-39 to -8) 
5'-C C C A T C C A A G T A C A T C G A A T T C A T G A C-3'
3'-G G G T A G G T T C A T G T A G C T T A A G T A C T G-5'
HIV-1 Promoter Scanning
5'-G A G C T C G T C C T C A G A T G C T G C A T A T A A-3'
3'-C T C G A G C A G G A G T C T A C G A C G T A T A T T-5'
Acaete-scute Promoter  
5'-G C A T C G T A G C T C G T C A C G C G A C A G G G C-3'
3'-C G T A G C A T C G A G C A G T G C G C T G T C C C G-5'
HER2 Promoter   
5'-G G G C T G C T T G A G G A A G T A T A A G A A-3'
3'-C C C G A C G A A C T C C T T C A T A T T C T T-5'
HTLV-1 Promoter 
5'-C T C A G G C G T T G A C G A C A A C C C C T C-3'
3'-G A G T C C G C A A C T G C T G T T G G G G A G-5'
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HIV-1 LTR (+8 to +32) 
5'-T C T G G T T A G A C C A G A T C T G A G C C T-3'
3'-A G A C C A A T C T G G T C T A G A C T C G G A-5'
+
5S RNA promoter  
5'-C G G G C C T G G T T A G T A C T T G G A T G G G A G-3'
3'-G C C C G G A C C A A T C A T G A A C C T A C C C T C-5'
HIV-1 Promoter  
5'-T C A G A T G C T G C A T A T A A G C A G C T G C T T-3'
 
3'-A G T C T A C G A C G T A T A T T C G T C G A C G A A-5'+ +
+ ++
+ +
+ +
+ +
+ +
+
+
+
+
PR
R
+
+
TFIIA-TFIID
TBP
Ets-1 LEF-1
TBP
Deadpan
DNA gyrase
Tax CREB Tax
GCN4
TFIIIB or TBP
LSFLSF
5S RNA promoter  
5'-C G G G C C T G G T T A G T A C T T G G A T G G G A G-3'
3'-G C C C G G A C C A A T C A T G A A C C T A C C C T C-5'
+
5S RNA promoter (+63 to +89)  [45,46]
5S RNA promoter (+63 to +89)  [46]
HIV-1 Promoter  [47]
HIV-1 Promoter  [47,51]
HIV-1 Promoter Construct  [49]
Xenopus tRNA Promoter Construct (-39 to -8)  [48]
Achaete-scute Neural Promoter Construct  [50]
HER2/neu Promoter  [52]
HTLV-1 Promoter  [53]
designed construct from pBR322  [54]
designed construct ARE-1  [56]HIV-1 LTR (+8 to +32)  [61]
0.03 nM
2 nM
0.05 nM
0.06 nM0.05 nM
0.05 nM
0.4 nM
0.03 nM
0.07 nM
0.4 nM
0.1 nM
1 µM 1 µM
0.1 nM
2 nM0.7 nM 0.9 nM
TFIIIA  (zinc finger 4)
TFIIIA  (zinc finger 4)
Ets
 15
The question of whether polyamides can bind chromosomal DNA is important 
because the vast majority of the DNA in a cell is locked in nucleosomes.  In order to 
determine the binding characteristics of polyamides on the NCP, several X-ray crystal 
structures were completed of nucleosome core particles into which had been bound 
polyamides (Figure 1.10).53  The structures show that not only can polyamides bind 
nucleosomal DNA, they have some access to the internal regions of the nucleosome core 
particle, where they can co-localize with the histone proteins.  The only sites which were 
found to be inaccessible to polyamide binding were those blocked by the presence of the 
tails of the histone proteins in the minor groove. 
In order to access chromosomal DNA, polyamides must be able to localize to the 
nucleus of cells.  The cellular trafficking characteristics of polyamides have been studied 
by attachment of a fluorescent dye to a small selection of polyamides, exposing the 
resulting conjugates to various mammalian and insect cell lines, and viewing their 
Figure 1.9  Polyamide-peptide conjugates have successfully been used to activate 
transcription of a target gene in vitro.  In this experiment, the natural transcription 
factor (TF) activators (green ovals) have been replaced by polyamide-activator 
conjugates, binding the appropriate gene promoter sites.  These artificial TF’s 
interact with other transcription factors (purple ovals) and parts of the 
transcriptional machinery (yellow ovals), sometimes via mediating proteins (blue 
ovals) to recruit the transcriptional machinery to the target gene, initiating 
transcription. 
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subcellular localization by confocal laser scanning microscopy.54  These results showed 
that in a limited number of cell lines, primarily lines derived from mammalian T-cells, 
fluorescent polyamide conjugates could enter the cells and traffic to the nucleus (Figure 
1.11).  However, in most cell lines, these compounds either did not enter the cells, or 
entered the cells but were sequestered in the cytoplasm.   
This raises the issue of how might the uptake profile of polyamides and 
polyamide conjugates be altered in order that they be useful in the context of living 
Figure 1.10  X-ray crystal structure of a hairpin polyamide bound to the nucleosome 
core particle (NCP).  Top-down (a) and side-on (b) views of several polyamide 
molecules bound to the NCP.  Histone proteins are depicted as multicolored cartoons. 
(c) View down the minor “supergroove” in which are bound two hairpin polyamides. 
Figure 1.11  Cellular uptake of a fluorescent polyamide.  (a) Chemical structure and 
ball-and-stick representations of a hairpin polyamide labeled with the fluorophore 
Bodipy.  (b) CEM cells stained with Bodipy-polyamide.  At left is a fluorescence-only 
image, and at right is the bright-field image.  Polyamide is located in the nucleus. 
 17
organisms.  Several methods of altering the subcellular localization of molecules have 
been developed for medicinal chemistry and diagnostic applications.  The application of 
many of these methods to polyamides is the subject of the majority of this work.  By 
creating polyamides or polyamide conjugates that are able to localize to the nucleus of 
living cells, technology advances one step closer to in vivo regulation of gene 
transcription by small molecules. 
Figure 1.11  Cellular uptake of a fluorescent polyamide.  (a) Chemical structure and 
ball-and-stick representations of a hairpin polyamide labeled with the fluorophore 
Bodipy.  (b) CEM cells stained with Bodipy-polyamide.  At left is a fluorescence-only 
image, and at right is the bright-field image.  Polyamide is located in the nucleus. 
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Scope of This Work 
This thesis describes work examining DNA-binding polyamides in biological 
systems.  Chapter 2 is conceptually related to the transcription activation studies outlined 
as in Figure 1.9.  In previous work, polyamide-activation peptide conjugates had been 
synthesized with either short or long flexible linkers separating the two active domains.  
These compounds were efficient activators of transcription, though it was uncertain what 
effect the spacing between the activating domain and the DNA had on RNA Pol II 
recruitment and transcription activation.  In order to answer this question, a series of 
polyamide-polyproline-activation peptide compounds were synthesized and analyzed for 
their ability to activate transcription.  The polyproline domain is a rigid linker allowing 
discrete spacing studies to be undertaken.  These experiments, though successful in vitro, 
were not successful in vivo.  It was hypothesized that this result was due to poor cellular 
uptake properties. 
Chapter 3 details some attempts that were made to overcome poor cellular uptake 
and nuclear localization of polyamides.  Chapter 3A recounts the addition of peptide 
domains shown in other systems to increase the uptake of conjugated small molecules 
and oligonucleotides to polyamides, along with the fluorophore Bodipy.  Chapter 3B 
records the attachment of small molecules to polyamides in attempts to increase their 
cellular and nuclear localization.  The subcellular localization characteristics of these 
compounds were determined with confocal laser scanning microscopy.  Though largely 
unsuccessful, these experiments provided useful experience in microscopy and cell 
culture methods that were necessary to any successful uptake results. 
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Chapter 4 recounts the modification of polyamides with fluorescein and other 
structurally similar fluorophores, and the successful use of these compounds to stain 
nuclei of living cells.  Chapter 4A records early efforts to determine the uptake 
characteristics of hairpin polyamides conjugated to fluorescein isothiocyanate.  Chapter 
4B presents a much wider view of the uptake profiles of several polyamide motifs 
conjugated to a variety of fluorophores.  Chapter 4C is a first-pass overview of the DNA-
binding characteristics of these fluorophore conjugates, showing that the fluorescent 
compounds, themselves, are appropriate in many cases for use in transcription inhibition 
experiments in vivo.  Chapter 5 is a record of one such application, using polyamides and 
polyamide conjugates to inhibit the interaction of the androgen receptor with its cognate 
DNA-binding site. 
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Chapter 2 
 
Transcription Activation with Polyamide-Polyproline-Peptide Conjugates 
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Abstract 
Typical eukaryotic transcriptional activators are composed of distinct functional 
domains, including a DNA-binding domain and an activating domain.  Artificial 
transcription factors have been designed wherein the DNA-binding domain is a minor 
groove DNA-binding hairpin polyamide linked by a flexible tether to short activating 
peptides, typically 16-20 residues in size.  In this study, the linker between the polyamide 
and the peptide was altered in an incremental fashion using rigid oligoproline “molecular 
rulers” in the 18-45 Å length range.  We find that there is an optimal linker length which 
separates the DNA and the activation region for transcription activation. 
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Introduction 
Transcriptional activators typically bind near a gene and recruit the transcriptional 
machinery to a nearby promoter, thereby stimulating the expression of the gene.  These 
activators comprise two regions: the DNA binding domain and the activating domain.  
The former defines the promoter address in the genome where the activating region is to 
be delivered for recruitment of the transcriptional machinery.1,2  We have previously 
reported efforts to replace the natural protein activators with nonnatural components 
smaller in size than nature’s proteins.  Artificial transcription activators comprised of 
three synthetic modules, a hairpin polyamide (PA) DNA-binding domain (DBD) and a 
short peptide activation domain (AD) (typically 16-20 amino acid residues in size) 
connected by flexible linkers which vary in length, have been shown to initiate 
transcription at targeted promoter sites in cell-free systems.3,4  Modeling studies on these 
polyamide-peptide conjugates with flexible linkers suggested a distance of 20-40 Å 
between the DNA and the activating region for transcription activation.  We sought to 
determine whether the length of the linker that projected the activating region away from 
the DNA would have any effect on the degree of activation (Figure 2.1).  In the present 
study, we replaced the flexible linkers between the DBD and AD with rigid oligoprolines 
of varying incremental lengths (18-45 Å).  Our results suggest that there is an optimal 
window within which activating regions of the type used here can function efficiently. 
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Results 
In this study, we replaced the flexible linker between the activating peptide and 
the hairpin polyamides with 6, 9, 12, and 15 L-proline residues (Pro6-Pro15) (Figure 2.2).  
Poly-L-proline linkers were chosen as the “molecular rulers” for the present study since a 
stretch of proline residues forms a stable helical structure (the polyproline II helix).   
Addition of each proline residue increases the length of this helix in a predictable 
manner, approximately 3 Å per proline residue.  Thus, the oligoproline linker projects the 
activating region peptide away from the DNA-binding polyamide in an incremental 
manner spanning 18, 27, 36, and 45 Å (Figure 2.2).5  For the activating region we used 
two peptides, AH and VP2, that have been previously shown to function efficiently when 
tethered to a hairpin polyamide (Figure 2.3a).4  Therefore, three series were synthesized:  
Figure 2.1  Activation of gene transcription by artificial transcription factors.   The 
artificial activator is composed of three separate functional domains.   The DNA 
binding domain consists of minor groove-binding pyrrole/imidazole polyamides.  The 
DNA-binding domain is tethered to the activation domain (AD), a peptide, by a linker 
domain. 
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Figure 2.2  Poly-L-proline-based molecular rulers.   (a) Structure of a poly-L-proline 
helix.   (b) Predicted length of polyproline helices containing the indicated numbers of 
proline residues. 
Figure 2.3  Structures of polyamide-activation peptide conjugates 1-5 prepared to 
explore the effect of linker length and flexibility on activation potential. (a) 
Polyamide-Pron-peptide conjugates for which the linker domain consisting of poly-L-
proline helices serves as a molecular ruler.  (b) Polyamide-peptide conjugates bearing 
a flexible linker. 
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PAPro6-15-AH (2a-d), PA-Pro6-15-VP2 (3a-d), and PA-Pro6-15 (1a-d) lacking the 
activation peptides as controls.   Conjugates with flexible poly(ethylene glycol) linkers, 4 
and 5, previously shown to activate transcription in vitro were included for comparison 
(Figure 2.3b).4   
The eight-ring hairpin polyamides which target 5’-WGWWWW-3’ (W = A or T) 
and two peptides, AH and VP2, were synthesized by solid-phase methods.6  Each 
activating peptide contained an N-terminal cysteine for subsequent reaction with a 
thioester, 6, via the native ligation reaction to afford the desired conjugate (Figure 2.4).7  
The ability of these conjugates, 1a-d, 2a-d, and 3a-d, to activate transcription in vitro 
was tested using yeast nuclear extract on a template bearing three palindromic binding 
sites upstream of the minimal core promoter driving the expression of a transcript that 
Figure 2.4  Synthesis of polyamide-peptide conjugates. Thiolane 6 was converted to 
the targeted conjugates via the native ligation reaction. 
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lacks guanine residues.3,4  The results show that the linker plays a role in determining the 
ability of the activating region to stimulate in vitro transcription (Figure 2.5).  This effect 
is not a function of the activating peptide, as both activating peptides tested showed 
similar profiles.  Figure 2.5 also compares the two activating peptides attached to the 
polyamide via different proline linkers to conjugates 4 and 5 bearing the same activating 
peptides via flexible linkers. 
 
Figure 2.5  In vitro transcription reactions with the compounds listed in Figure 2.3;
the transcription reaction conditions are described in the Experimental Section.  (a) 
Storage phosphor autoradiogram of the reactions which were performed with a 400 
nM concentration of each conjugate.  The template configuration showing the 
sequence and number of the polyamide binding sites is depicted below the gel.  (b) 
Fold activation was determined by comparing the amount of transcription elicited by 
conjugates 2a-d, 3a-d, 4, and 5 with that of the basal level. 
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Our results indicate that the strength of the given activating peptide increases with 
every increment in the spacer length up to 12 residues (36 Å).  An increase in the spacer 
length to 15 residues leads to a decrease in activation.  These results suggest an optimal 
spacing of 36-45 Å between the DNA and the activating regions for efficient 
transcription.  Figure 2.6 shows the relative potency of each compound in comparison to 
PA-Pro6-AD (2a, AD = AH; 3a, AD = VP2).  Although the absolute fold activation 
mediated by all conjugates varies slightly between different experiments, the overall 
relationship between linker length and activation potential remains constant over four 
independent in vitro transcription reactions.   
To determine whether any of the effects observed were due to inefficient or 
inappropriate binding of the conjugate to its site on the promoter, we measured 
dissociation constants for conjugates 3a-d using quantitative DNase I footprinting 
titrations.8,9  These studies revealed that conjugates bound with similar affinities and 
specificities to their sites on the promoter DNA (Figure 2.7 and Table 2.1).  In control 
Figure 2.6  Summary of four independent in vitro transcription reactions showing the 
relative potency of each compound in comparison to PA-Pro6-AD (2a, AD = AH; 3a, 
AD = VP2). 
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experiments polyamide-proline conjugates 1a-d lacking the activation transcription 
peptides did not activate.    
Figure 2.7  Quantitative DNase I footprinting titration of conjugates 3a-d shows that all 
conjugates bound to their target sites with similar affinities. (Top) Storage phosphor 
autoradiogram of a quantitative DNase I footprinting titration of 3a-d on a  63 bp 5’-32P-
labeled PCR fragment containing both the promoter region and 140 bp of the G-less 
cassette reporter.  (a) Lane 1, undigested DNA; lane 2, A reaction; lane 3, G reaction; 
lane 4, DNase I standard;  lanes 5-14, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 
nM, 20 nM, 50 nM, and 100 nM 3a, respectively.  (b) Lane 1, undigested DNA; lane 2, 
A reaction; lane 3, G  reaction, lane 4, DNase I standard; lanes 5-14, 100 pM, 200 pM, 
500 pM, 1 nM, 2 nM, 5 nM, 10 nM, 20 nM, 50 nM, and 100 nM 3b, respectively. (c) 
Lane 1, undigested DNA; lane 2, G reaction; lane 3, A reaction; lane 4, DNase I 
standard; lanes 5-14, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM, 20 nM, 50 
nM, and 100 nM 3c, respectively.  (d) Lane 1, undigested DNA; lane 2, G reaction; lane 
3, A reaction; lane 4, DNase I standard; lanes 5-14, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 
10 nM, 20 nM, 50 nM, 100 nM, and 200 nM 3d, respectively. (Bottom) Design of the 
plasmid DNA template used for the DNase I footprinting titration experiments. The 
promoter region contains six cognate binding sites for the hairpin polyamide upstream of 
a G-less cassette reporter. 
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The use of poly-L-proline linkers as molecular rulers was inspired by the seminal 
work of Stryer and co-workers, who utilized fluorescence resonance energy transfer 
(FRET) analysis to show that oligomers composed of up to 12 proline residues can retain 
a rigid helical structure.5  To ascertain that an oligomer composed of 15 proline residues 
does not deviate from the predicted structure, we repeated the FRET analysis on poly-L-
proline linkers used in our experiments.  To perform this analysis, we synthesized poly-L-
proline linkers bearing Oregon Green (OG) energy donor and tetramethylrhodamine 
(TAMRA) energy acceptor moieties on each end (conjugates 7a-d, Figure 2.8).  In the 
Stryer study, naphthyl and dansyl groups were used as the energy donor and the energy 
acceptor moieties, respectively.  The different dyes were used in the present study 
because the Förster radius (the distance at which energy transfer is 50% efficient) for the 
dansyl-naphthyl pair (Ro = 27 Å) may be too low to allow for efficient FRET when the 
energy donor and the acceptor are spaced by the Pro15 linker (45 Å).  The Förster radius 
(Ro) for the OG-TAMRA pair is predicted to be 55 Å.10  FRET measurements indicate 
that the oligomer composed of 15 proline units does retain a rigid structure.  The plot of 
distance versus FRET efficiency provides a linear relationship between the conjugates, 
and importantly, the experimentally observed FRET efficiency is in good agreement with 
the predicted r-6 dependence (Figure 2.9).5  Thus, the FRET studies show that the 
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dependence of transcription activation on the number of L-prolines is not due to a change 
in the linker structure. 
 
Discussion 
In this study we examine the role of the distance separating the DBD and AD in 
our artificial transcription factors.  This study was prompted by previous observations in 
Figure 2.8  Synthesis of polyproline-dye conjugates.  (i) 20% hydrazine in ethanol. 
(ii) Oregon Green-NHS ester, DMF, and DIEA.  (iii) 20% TFA in CH2Cl2.  (iv) 
TAMRA-NHS ester, DMF, and DIEA. 
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which we found that activating regions activated transcription to different degrees on the 
basis of the point of attachment as well as the nature of the linker separating them from 
the DNA binding polyamide.4  This dependence on spatial presentation led us to test the 
role of linker length in the degree of activation elicited by two acidic activating peptides.   
The proline linker domain is conjugated to an internal pyrrole of the polyamide, rather 
than to the C-terminus, which allows the linkers to project out of the minor groove away 
from the DNA helix.  Our data suggest that for the two acidic activating regions (AH and 
VP2) the strength of activation increases as the linker reaches a length of 36 Å.  The 
increase, while modest, is reproducible and displays a clear trend (Figures 2.5 and 2.6).   
The effects are muted in part due to three features that were incorporated into the 
experimental design: the use of multiple DNA binding sites to elicit robust activation, the 
presence of a flexible hinge tethering the proline linker to the polyamide, and the 
Figure 2.9  FRET data for polyproline helices.  (a) The emission spectra of OG-Pron-
TAMRA conjugates.  The conjugates were excited at 495 nm.  (b) The dependence of 
the efficiency of energy transfer on distance is given in this plot of ln (E-1 – 1) vs. ln r. 
The slope is 6.6, in good agreement with the predicted r-6 dependence. 
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unstructured nature of the activating peptides, which themselves may sample a significant 
amount of solvent space when fully extended.    
We did not find a significant contribution of poly-L-proline linkers themselves to 
the level of activation in the absence of tethered activating regions.  It has been reported 
that proline-rich (rather than poly-L-proline) activating domains can function to activate 
transcription even in yeast extracts, though this activation is not as robust as that elicited 
by acidic activators.11  Presumably the proline oligomer is not a sufficiently strong 
activator; its effects are therefore not detected in our studies.   An alternative possibility is 
that the ability of proline-rich activating domains to elicit transcription may be more 
sensitive to their spatial location.    
As the principle of recruitment implies, for a DNA-tethered activator to function 
efficiently, it must sample sufficient nuclear solvent space to bind and recruit various 
complexes that participate in transcriptional initiation to a given promoter.   However, 
beyond a certain distance the activating region would not function to recruit, as the local 
concentration of the machinery at a given promoter would not be tremendously enhanced 
by binding a distant activating region.  It has been shown that eukaryotic activating 
regions that are not tethered to DNA—even when presented at exceedingly high 
concentrations such that it would bind to its targets in the transcriptional machinery—do 
not improve the level of transcription from a given promoter.  In fact, as expected, it 
“squelches” the ability of a DNA-bound activator from functioning—presumably by 
binding the targets in the machinery.2,3,12  Thus, for efficient recruitment in the context of 
our in vitro studies with artificial activators on nonchromatinized templates using yeast 
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extracts, we find that a spacing of 36-45 Å serves as an optimal distance between the 
DNA and the activating regions to elicit transcriptional activation.    
This work is a step forward toward the goal of engineering and integrating at the 
molecular level the components for functional artificial transcription factors.  The field is 
at an early stage, and one can imagine other components replacing the design reported 
here, such as triple-helix-forming oligonucleotides or PNAs tethered to activating 
peptides.13,14  Long-term goals for the field would be the replacement of the activating 
peptide with nonpeptide constructs and the activation (or repression) of endogenous 
genes in cell culture experiments. 
 
Experimental Section 
Synthesis of Polyamide-Peptide Conjugates 1-3 
Polyamide thioester 6 was transformed into conjugates 1a-d, 2a-d, and 3a-d by 
previously reported methods.7 The identities of all conjugates were verified by MALDI-
TOF mass spectrometry.   Characterization: 1a (PA-Pro6), MALDI-TOF [M+H]+ 
(monoisotopic mass) calcd 2050.6, obsd 2050.0; 1b (PA-Pro9), MALDI-TOF [M+H]+ 
(average mass) calcd 2341.9, obsd 2341.4; 1c (PA-Pro12), MALDI-TOF [M+H]+ (average 
mass) calcd 2633.3, obsd 2633.1; 1d (PA-Pro15), MALDI-TOF [M+H]+ (average mass) 
calcd 2924.6, obsd 2925.1; 2a (PAPro6-AH), MALDI-TOF [M+H]+ (average mass) calcd 
4354.5, obsd 4354.8; 2b (PA-Pro9-AH), MALDI-TOF [M+H]+ (average mass) calcd 
4646.8, obsd 4647.5; 2c (PA-Pro12-AH), MALDI-TOF [M-H]- (average mass) calcd 
4937.5, obsd 4937.5; 2d (PA-Pro15-AH), MALDI-TOF [M+H]+ (average mass) calcd 
5228.7, obsd 5229.2; 3a (PA-Pro6-VP2), MALDI-TOF [M+H]+ (average mass) calcd 
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3862.3, obsd 3862.7; 3b (PA-Pro9-VP2), MALDI-TOF [M+H]+ (average mass) calcd 
4153.7, obsd 4154.8; 3c (PA-Pro12-VP2), MALDI-TOF [M-H]+- (average mass) calcd 
4445.0, obsd 4445.3; 3d (PA-Pro15-VP2), MALDI-TOF [M+H]+ (average mass) calcd 
4736.3, obsd 4736.8. 
 
Synthesis of Poly-L-proline -Dye Conjugates 7a-d 
 Poly-L-proline peptides of lengths n proline residues, where n = 6, 9, 12, 15, were 
individually synthesized by standard t-Boc solid phase methods, retaining the n-terminal 
t-Boc protecting group.  All peptides were cleaved from resin by treatment with 20% 
(v/v) anhydrous hydrazine in absolute ethanol for 18 hrs at room temperature.  Peptides 
were purified by reverse-phase HPLC, and lyophilized to provide white powders.  
Purified peptides (2.5 µmoles) were treated with the 5-N-hydrosuccinimidyl ester of 
Oregon Green 488 (OG, Molecular Probes) (5.0 µmoles), DMF (100 µL), and N,N-
diisopropylethylamine (20 µL), and purified by reverse-phase HPLC to yield C-terminal 
dye intermediates.  The N-terminal t-Boc group was removed by treatment with 20% 
TFA in CH2Cl2 and the resulting molecules were treated with the 5-N-hydrosuccinimidyl 
ester of tetramethylrhodamine (TAMRA, Molecular Probes) (5.0 µmoles), DMF (100 
µL) and N,N-diisopropylethylamine (20 µL).  Purification by reverse-phase HPLC 
afforded dye conjugates 7a-e (typical isolated yields: 20-40%).  The identity of all 
conjugates was verified by MALDI-TOF mass spectrometry.  Characterization: 7a 
(TAMRA-Pro6-OG):  MALDI-TOF [M+H]+ (monoisotopic mass) calcd 1422.5, obsd 
1422.6; 7b (TAMRA-Pro9-OG):  MALDI-TOF [M+H]+ (monoisotopic mass) calcd 
1712.7, obsd 1712.5; 7c (TAMRA-Pro12-OG):  MALDI-TOF [M+H]+ (monoisotopic 
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mass) calcd 2003.8, obsd 2003.9; 7d (TAMRA-Pro15-OG):  MALDI-TOF [M+H]+ 
(monoisotopic mass) calcd 2295.0, obsd 2295.2. 
 
Fluorescence Resonance Energy Transfer Experiments 
 Fluorescence emission spectra were collected on an ISS-K2 fluorometer.  
Solutions (25 nM) of conjugates 7a-d, Oregon Green, and TAMRA were prepared in 1:1 
methanol:bicarbonate buffer (150 mM, pH 8.3).  The emission spectra of these solutions 
were collected from 500-640 nm, with an excitation wavelength of 495 nm. 
 
DNase I Footprinting Titration Experiments 
A 363 bp 5’ 32P-labeled PCR fragment was generated from template plasmid 
pAZA812 in accordance with standard protocols and isolated by nondenaturing gel 
electrophoresis.  All DNase I footprinting reactions were carried out in a volume of 400 
µL.  A polyamide stock solution or water (for reference lanes) was added to TKMC 
buffer, with final concentrations of 50 mM Tris-HCl, 50 mM KCl, 50 mM MgCl2, and 25 
mM CaCl2, pH 7.0, and 15 kcpm 5’-radiolabeled DNA.  The solutions were equilibrated 
for 12-18 h at 22°C.  Cleavage was initiated by the addition of 10 µL of a DNase I stock 
solution and was allowed to proceed for 7 min at 22°C.  The reactions were stopped by 
adding 50 µL of a solution containing 2.25 M NaCl, 150 mM EDTA, 0.6 mg/mL 
glycogen, and 30 µM base pair calf thymus DNA and then ethanolprecipitated.   The 
cleavage products were resuspended in 100 mM Trisborate-EDTA/80% formamide 
loading buffer, denatured at 85°C for 10 min, and immediately loaded onto an 8% 
denaturing polyacrylamide gel (5% cross-link, 7 M urea) at 2000 V for 2 h and 15 min.   
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The gels were dried under vacuum at 80 °C and quantitated using storage phosphor 
technology. 
 
In Vitro Transcription Assays 
Template plasmid pAZA812 was constructed by cloning a 78 bp oligomer bearing 
three cognate palindromic sequences for conjugates 1a-d, 2a-d, and 3a-d into a Bgl2 site 
30 bp upstream of the TATA box of pML∆53.  This plasmid has the AdML TATA box 
30 bp upstream of a 277 bp G-less cassette.   For each reaction, 20 ng of plasmid (30 
fmol of palindromic sites) was preincubated with a 400 nM concentration of the 
compound for 75 min prior to the addition of 90 ng of yeast nuclear extract in a 25 µL 
reaction volume.  The reactions were performed as previously described and resolved on 
8% 30:1 polyacrylamide gels containing 8 M urea.  The gels were dried and exposed to 
photostimulatable phosphorimaging plates (Fuji Photo Film Co.).  The data were 
visualized using a Fuji phosphorimager followed by quantitation using MacBAS software 
(Fuji Photo Film Co.). 
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Cellular Uptake Studies 
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Chapter 3A 
 
Polyamide-Peptide Conjugates for Cellular Uptake Studies 
 
Abstract 
In order that polyamides or polyamide-peptide conjugates be useful as diagnostic 
or therapeutic tools in living organisms, they must be able to cross the cellular membrane 
of cells within target tissues and transit to the nuclei of those cells.  In proof-of-principle 
in vitro experiments polyamides were shown to inhibit the transcription of target genes, 
presumably by competing against natural transcription factors for promoter binding sites.  
In other in vitro experiments polyamide-peptide conjugates were shown to activate 
transcription of target genes, presumably by recruitment of the RNA polymerase II 
holoenzyme to promoter regions.  Attempts to duplicate these successes in living model 
systems met with limited success.   
It was postulated that the difficulty in transferring successful in vitro results to 
living systems lay in the inability of polyamides to cross cell membranes.  In order to 
overcome this challenge, polyamides were conjugated to peptides shown to increase 
cellular uptake and to small molecules that might be recognized by cellular receptors, 
facilitating polyamide influx into the cell.  Polyamides were also added to cells in growth 
medium containing drugs shown to induce cellular uptake of certain compounds.  Though 
meeting with little initial success, these attempts increased the body of knowledge of how 
polyamide conjugates interact with DNA, how they interact with cells, and laid the 
groundwork for more successful experiments documented in Chapter 4.  
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Introduction 
Polyamides are inherently interesting as probes of DNA recognition, due to the 
modularity of their design and their resulting ability to target nucleic acid sequences in a 
programmed manner.  These molecular tools have been used effectively in several in 
vitro systems to regulate gene processing.  As inhibitors of transcription, polyamides 
have been quite effective in a number of model systems (Figure 1.8).  Once conjugated to 
activation peptides, polyamides have also functioned as transcriptional activators 
(Chapter 2).  Ultimately it is desirable that polyamides have the capacity to affect the 
transcriptional machinery in cell cultures and living organisms.  Studies with the human 
immunodeficiency virus (HIV) promoter and inhibition of viral replication provided early 
examples of the successful application of polyamides as potent regulators in primary 
human lymphocytes1, as well as in live-cell models.2  Polyamides were also effective in 
causing gain- or loss-of-function phenotypes when fed to Drosophila melanogaster.3,4 
Attempts to inhibit the transcription of endogenous genes in cell lines other than 
insect or T-lymphocytes have met with little success.  For example, polyamides targeted 
to the Ets binding site of the HER2/neu promoter were shown to inhibit binding of the 
transcription factor ESX at nanomolar concentrations and to inhibit transcription of the 
HER2/neu gene in cell-free experiments.5  However, those polyamides display no activity 
in HER2-overexpressing SKBR-3 cells.6  In an attempt to determine the reason why no 
inhibition of transcription was observed in the cell-based assay, fluorescent conjugates of 
polyamides attached to the Bodipy FL fluorophore were synthesized.  These compounds 
were then applied to SKBR-3 cells and imaged by laser scanning confocal microscopy.  
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The polyamide conjugates were not seen to localize in the nucleus of the living cells, 
rather they were sequestered in the cytoplasm.6 
In order to more generally determine the cellular localization characteristics of 
polyamides, a small series of polyamide-Bodipy conjugates were synthesized, applied to 
a variety of cell lines, and imaged by confocal microscopy (Figure 3.1).7  With the  
Figure 3.1  Localization of polyamide–Bodipy conjugates in live cells as determined 
by confocal microscopy.  (a) Chemical structures and ball-and-stick models of 
polyamide-Bodipy conjugates.  (b) The designation ‘nucleus’ indicates observation of
fluorescence in the interior of the nucleus. The designation ‘cytoplasm’ indicates 
cellular, non-nuclear fluorescence.  Cells were imaged directly following 20 h 
incubation with 5 µM 1–3 under normal growth conditions for each cell-line.7 
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exception of human T-cells and T-cell-derived cell lines, polyamide conjugates 1-3 
localized in the cytoplasm of all cells tested (Figure 3.2).  This result suggested that 
transcriptional regulation experiments occurring in T-cells or T-cell-derived lines would 
not be negatively influenced by the cellular uptake of polyamides, while those in other 
cell lines were prohibited from showing positive results due to poor polyamide uptake. 
In order to overcome cytoplasmic sequestration of polyamide-fluorophore 
conjugates, polyamides bearing both a Bodipy fluorophore and one of several carrier 
peptides were synthesized.  Carrier peptides have been used to transport small molecules, 
proteins, and oligonucleotides into both cells and nuclei.8  Two of the most widely-
Figure 3.2  Localization of 1 in live human cell lines.  (a) Conjugate 1 in live SKBR-3 
cells, showing cytoplasmic staining.  The fluorescent image is on the left, bright field 
image on the right.  Bar: 20 µm.  (b) Conjugate 1 in live CEM cells, showing nuclear 
staining.  The fluorescent image is on the left, bright field image on the right. Bar: 20 
µm.7 
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studied carrier peptides are TAT,9-12 a basic domain derived from the HIV-1 Tat 
protein,13 and the simian vacuolating virus-40 (SV-40) nuclear localization sequence 
(NLS) peptide,14-17 derived from a basic region from the SV40 T-antigen protein.18  The 
NLS is known to be recognized by a specific membrane protein receptor, karyopherin 
α.18,19  The mechanism of TAT transduction is unknown, appearing not to involve 
receptor-, transporter-, endosome-, or adsorptive-endocytosis-mediated processes.8,20  
Since TAT-mediated uptake bypasses known endosomal routes, TAT is known to be a 
nuclear localization signal,21 and since polyamide-Bodipy conjugates localize to the 
cytoplasm in discrete spots, possibly endosomes, TAT-polyamide-Bodipy conjugates 
should be expected to transit to the nucleus. 
Several synthetic derivatives of TAT showing increased ability to facilitate uptake 
have been developed.  Polyarginine peptide Arg9 was created by Wender and co-workers 
as an analog of TAT.  It was shown that (D) Arg9 outperformed TAT in terms of uptake 
into Jurkat cells.22  TAT* was developed by Dowdy and co-workers through alanine 
scanning to be a helical mimetic of TAT bearing a minimum number of arginine 
residues.23  TAT* peptides composed of both L- and D-amino acids have been shown to 
be active uptake carriers.  Peptides composed of D-amino acids are expected to have 
greater stability to proteolytic degradation than their natural counterparts of L-chirality. 
Carrier peptide-polyamide-Bodipy conjugates 4-7 (Figure 3.3a) were synthesized 
and tested for their ability to stain the nuclei of several cell lines.  TAT-polyamide-
Bodipy and (D) Arg9-polyamide-Bodipy conjugates 5 and 7 were observed to stain the 
nuclei of most cell lines tested, while NLS- and (D) TAT*-conjugates 4 and 6 generally 
were found to localize in the cytoplasm or extracellular medium (Figure 3.3b).  It was 
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Figure 3.3  Localization of peptide-polyamide–Bodipy conjugates in live cells as 
determined by confocal microscopy.  (a) Chemical structures and ball-and-stick 
models of peptide-polyamide-Bodipy conjugates.  (b) The designation ‘nuclear’ 
indicates observation of fluorescence in the interior of the nucleus. The designation 
‘cytoplasm’ indicates cellular, non-nuclear fluorescence.  The designation ‘non-
cellular’ indicates extracellular fluorescence.  Cells were imaged directly following 20 
h incubation with 5 µM 4–7 under normal growth conditions for each cell line.25 
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also found that 5 and 7 tended to be toxic to most cell lines at the concentration used in 
the assay (5 µM).  In order to determine the DNA-binding qualities of polyamide-peptide 
Figure 3.4  DNA-binding characteristics of tail-linked polyamide-peptide conjugates. 
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conjugates, compounds 8-11 (Figure 3.4a) were synthesized and tested by DNase I 
footprinting titration.24  All compounds bound DNA at concentrations at or below 50 nM, 
with varying degrees of specificity over non-match binding sites.  TAT- and (D) Arg9-
polyamide conjugates 9 and 11 coated DNA, showing no specificity for any binding site 
over any other.  NLS- and (D) TAT*-polyamide conjugates 8 and 10 bound DNA with a 
specificity for their match sites over all other sites (coating) of 20-fold (Figure 3.4b).25 
In order to improve the DNA-binding characteristics of polyamide-peptide 
conjugates, the peptide moiety was moved from the tail to the N-methyl position of an 
internal pyrrole.  This arrangement removes the cationic peptides from the DNA minor 
groove, with the goal of providing compounds with increased affinity and specificity, 
hopefully retaining or improving their uptake characteristics.  Peptide-polyamide-Bodipy 
conjugates 12-14 were synthesized and assayed for their uptake characteristics (Figure 
3.5).  These compounds had generally poorer uptake characteristics than the tail-linked 
cognates.  Polyamide-peptide conjugates 15-17 were then synthesized and assayed for 
their DNA-binding qualities.   
Compounds bearing up to five cationic charges exhibited specificity for binding 
the DNA match site, at generally higher affinities than the tail-linked counterparts (Figure 
3.6).  The good uptake characteristics of tail-linked conjugates and the good DNA-
binding characteristics of N-methyl-linked compounds suggest that molecular shape is an 
important variable regarding polyamide-peptide conjugates.  It was desirable to design a 
system that incorporated shape characteristics that would promote both good uptake and 
good DNA affinity and specificity.  Such a situation might be achieved by compounds 
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bearing the peptide moiety on the terminal imidazole residue, rather than an internal 
residue (Figure 3.7). 
Figure 3.5  Localization of N-methyl-linked peptide-polyamide–Bodipy conjugates.25 
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Figure 3.6  DNA-binding characteristics of N-methyl-linked polyamide-peptide 
conjugates.25 
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Results 
 N-terminal imidazole-linked peptide-polyamide-Bodipy conjugates 19-24 (Figure 
3.8) were synthesized as shown in Figure 3.9.  For the conjugation of the peptides to the 
polyamide, a maleimide-thiol Michael addition reaction was utilized because this reaction 
proceeds rapidly and selectively in aqueous buffers a physiological conditions.  
Compounds were added to a panel of fourteen cell lines, consisting of ten human cell 
lines (PC3, CEM, K562, NB4, MEG, HeLa, Jurkat, SKBR-3, MCF-7, and 786O), two 
mouse lines (3T3 and MEL), and two insect lines (KC and SF-9).  These cell lines 
represent a wide variety of human cancers, including hard-to-treat varieties such as 
kidney (786O) and ovarian (HeLa) cancer.  Treated cells were imaged by confocal 
microscopy and assayed for the localization of fluorescence (Figure 3.10). 
Figure 3.7  Effect of molecular shape on uptake and DNA-binding properties. 
Attachment of carrier peptides to the terminal imidazole’s N-methyl position should 
combine the good uptake properties of tail-linked conjugates and the good DNA-
binding properties of N-methyl-linked conjugates. 
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Figure 3.8  N-terminal imidazole-linked peptide-polyamide-Bodipy conjugates for 
nuclear uptake studies. 
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Figure 3.9  Synthesis of a representative compound in the N-terminal-linked series. 
(i) 1:1 mixture of methylamine (2M in THF):CH2Cl2, 6 hrs at 37ºC.  (ii) 20% TFA in 
CH2Cl2 (v/v), 30 min at room temperature.  (iii) 26, HOBt, DCC, DIEA, DMF.  (iv) 
20% TFA in CH2Cl2 (v/v), 30 min at room temperature.  (v) Bodipy-FL, DCC, HOBt, 
DIEA, DMF.  (vi) TCEP, (D) Cys-TAT*, 6M Gn·HCl, pH = 7.0, DMF, 30 min at 
room temperature. 
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Figure 3.10  Localization of 19-24 in live cells as determined by confocal microscopy.
(a) The designation ‘nuc’ indicates observation of fluorescence in the interior of the 
nucleus. The designation ‘cyt’ indicates cellular, non-nuclear fluorescence. The 
designation ‘toxic’ indicates compound induces toxicity at the concentration studied.
Cells were imaged directly following 20 h incubation with 5 µM 19–24 under normal 
growth conditions for each cell-line.  (b) Images of 19-24 and dead-cell stain Sytox 
orange in NB4 cells. 
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 In general, compounds 19-24 showed poor cellular uptake characteristics similar 
to those found in internal N-methyl-linked conjugates 15-18.  Conjugates 19-21 were 
found to be cytoplasmic (or in the case of Jurkat, toxic) in all cell lines studied.  
Polyarginine conjugates 22-24 showed either cytoplasmic staining or toxicity, with Arg9 
conjugate 23 being the most toxic compound in each human cell line studied.  The sole 
entry showing somewhat promising localization was compound 24 in NB4 cells.  The (R-
Ahx)6R peptide was developed by Wender and co-workers as a superior carrier peptide in 
jurkat cells.26  In this assay it was generally too toxic to be useful as a carrier at the 
concentrations studied. 
 Though the uptake characteristics of the N-terminal imidazole-linked peptide 
conjugates were not promising, the DNA-binding characteristics of this system were 
nonetheless interesting to determine.  To that end, compounds 27-32 (Figure 3.11) were 
synthesized and assayed by DNase I footprinting on the plasmid pDEH9, which bears a 
match 5’-TGGTCA-3’ site and discrete mismatch binding sites 5’-TGGCCA-3’ and 5’-
TGGGCA-3’ for the polyamide unit used in this study (Figure 3.12a).  Analysis of the 
footprinting gels (Figure 3.12b) shows that the DNA-binding characteristics of N-
terminal-linked conjugates are intermediate between tail linkage and internal N-methyl 
linkage.  (D) TAT*- and NLS-conjugates 27 and 28 show the best specificity for their 
DNA match site over nonspecific binding (coating).  Surprisingly, the (R-Ahx)6R-
conjugate 32 shows some specificity for its match site over coating (10-20 fold) even 
though the R7-conjugate 30, bearing the same overall molecular charge, shows negligible 
specificity over coating.  The poor DNA-binding qualities of the polyarginine conjugates, 
coupled with their toxicity to cells, makes them unsuitable for conjugation to polyamides 
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Figure 3.11  N-terminal imidazole-linked polyamide-peptide conjugates for 
footprinting studies. 
 60
Figure 3.12  DNA-binding characteristics of N-terminal imidazole-linked polyamide-
peptide conjugates.  (a) Plasmid pDEH9 illustrating match and mismatch sites for the 
polyamide used in this study.  (b) DNase I footprinting gels for 27-32, showing 
isotherms where measurable. 
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Figure 3.12  DNA-binding characteristics of N-terminal imidazole-linked polyamide-
peptide conjugates.  (c) Comparison of DNA-binding characteristics of carrier peptide-
polyamide conjugates in three morphologies.  In general 27-32 possess intermediate 
binding characteristics between tail-linked 8-11 and internally-linked 15-18. 
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for use as DNA-binding ligands in living systems.   
 One possible way to overcome the poor DNA-binding characteristics of carrier 
peptide-polyamide conjugates is by employing a pro-drug approach, attaching a carrier 
moiety to a polyamide via a linking domain that will be cleaved upon entering the 
cellular environment.  One such linking strategy is the disulfide bond, which is cleaved 
upon entering the reductive cytoplasmic environment to the constituent thiols.8  This 
strategy was implemented by the synthesis of compounds 33 and 34, containing a 
Bodipy-polyamide moiety linked to either (D) TAT* or Arg9 through a disulfide bond 
Figure 3.13  Disulfide-linked polyamide-peptide prodrugs.  (a) Chemical structures 
and ball-and-stick models of 33 and 34.  (b) Uptake profile of disulfide conjugates in 
nine mammalian cell lines. 
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(Figure 3.13a).  These conjugates were synthesized according to the scheme outlined in 
Figure 3.14.  Upon exposure to a panel of mammalian cell lines, 33 and 34 were assayed 
for cellular uptake by confocal microscopy (Figure 3.13b).  Unfortunately, neither 
conjugate was successful in staining the nucleus of any cell line.  Arg9 remained a toxic 
constituent in some cell lines.  In general, carrier peptide conjugates do not seem to be a 
fruitful path forward in promoting uptake of polyamides.  It is likely that small-molecule 
conjugates will be a more successful approach to the problem of utilizing polyamides in 
living systems. 
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Figure 3.14  Synthesis of disulfide conjugates.  (i) 20% piperidine/DMF (v/v), 30 min 
at room temperature.  (ii) Boc2O, DIEA, DMF.  (iii) 3,3’-diamino-N-
methyldipropylamine, 6 hr at 37ºC.  (iv) S-trityl-3-mercaptopropionic acid, HOBt, 
DCC, DIEA, DMF.  (v) 50% TFA in CH2Cl2 (v/v), 1 hr at room temperature.  (vi) 
Bodipy-FL, HOBt, DCC, DIEA, DMF.  (vii) 3-dimethylaminopropylamine, 2 hr at 
37ºC.  (viii), 2-Aldrithiol, (D) Cys-TAT*, DMF, 4 hrs at room temperature. 
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Chapter 3B 
 
Polyamide-Small Molecule Conjugates for Cellular Uptake Studies 
 
Introduction 
Continuing experiments aimed at creating polyamides or polyamide conjugates 
that cross the outer membranes of living cells and transit to the nucleus resulted in the 
creation of several small molecule-polyamide conjugates.  The first series of such 
compounds studied incorporated the DNA-alkylating agent chlorambucil (CHL, 35).  The 
laboratories of both Terry Beerman and Joel Gottesfeld have observed effects such as 
toxicity and DNA-alkylation in a variety of cell lines with polyamide-CHL conjugates.29  
As they were producing an effect in living cells, it was interesting to test Bodipy-
polyamide-CHL conjugates for cellular localization.  Compounds 36-38 were synthesized 
and tested in a wide panel of cell lines, localizing to the cytoplasm of all cell lines save 
NB4, CEM, and human primary CD4+ T-cells (Figure 3.15).  These cell lines exhibited 
nuclear staining upon treatment with 36 and 37, without accompanying toxicity at the 
concentration studied (5 µM).   
The successful staining of NB4 nuclei suggested that further attempts to optimize 
the uptake characteristics of Bodipy-polyamide-CHL conjugates might meet with some 
success.  Many small molecules serving as nutrients or signal transduction messengers 
are taken up into cells by specific transmembrane protein receptors.  It has been shown 
that the cellular uptake of several types of biopolymers, including DNA, peptide nucleic 
acids, and proteins, can be increased when attached to receptor-specific small 
molecules.30-32  The folate receptor is a frequent target of these compounds, since its 
process of uptake by receptor-mediated endocytosis is well understood and the receptor is 
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overexpressed in several cancers.33  In order to exploit cell receptors as possible paths of 
cellular influx, Bodipy-polyamide conjugates with folic acid and cholic acid were 
synthesized and tested in cell uptake assays (Figure 3.16).  These compounds were 
ineffective at increasing cellular uptake in the standard panel of cell lines.  However, 
other small-molecule conjugates might have increased uptake if the operative receptor-
targeting moiety is attached to the polyamide at the optimal linkage site, using an optimal 
linking domain. 
Figure 3.15  Bodipy-polyamide-chlorambucil conjugates for cell uptake studies.  (a) 
Chemical structures and ball-and-stick models of chlorambucil, 35, and Bodipy-
polyamide-CHL conjugates 3629 and 37-3825.  (b) The designation ‘nuclear’ indicates 
observation of fluorescence in the interior of the nucleus. The designation ‘cyt’ 
indicates cellular, non-nuclear fluorescence. 
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Most fluorescent conjugates studied show localization in the cytoplasm of living 
cells in a punctate pattern.  This suggests that polyamides and polyamide conjugates are, 
by and large, able to cross the cellular membrane, but are then tied up in cytoplasmic 
vesicles such as endosomes or lysosomes.  Another possible method to increase the 
uptake of polyamides and polyamide conjugates in living cells is co-treatment of the cells 
with drugs.  A known endosomal disruption agent, chloroquine (41), was studied as one 
possible formulation agent for polyamide-Bodipy conjugate 2.34  At 10 µM added 
chloroquine, 2 was found to stain the nuclei of PC3 and MEL cells.  At higher 
chloroquine concentrations (~100 µM) the cells showed toxicity, illustrating that any 
added agent must be both potent and specific in its effect, in order that the triggering of 
stress mechanisms or apoptosis be avoided.   
The success of chloroquine in increasing the uptake of a polyamide conjugate 
suggests that other drugs, such as those known to inhibit the multidrug 
response (MDR) might be effective formulating agents.35 
Figure 3.16  Bodipy-polyamide-small molecule conjugates for cell uptake studies.25 
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Results 
Polyamide-chlorambucil conjugates 
Two Bodipy-polyamide-CHL conjugates were designed as alternate morphologies 
of 36-38 to hopefully increase their cellular uptake and nuclear staining properties 
beyond merely NB4, CEM, and CD4+ T-cells.  Compounds 42 and 43 were synthesized 
as in Figure 3.17.  The necessity of having three differentially-protected amine moieties 
on 43 led to the use of pyrrole monomer 46, possessing an N-propylamine masked as an 
azide.  After addition of the CHL moiety, the azide was cleanly and specifically 
converted to an amine via the Staudinger reaction, leaving the CHL moiety intact.  This 
strategy of amine protection/deprotection may prove useful in the future in the synthesis 
of complex polyamide conjugates.  Unfortunately, upon exposure to the standard panel of 
cell lines, both 42 and 43 were found to localize to the cytoplasm in all cases. 
 
Polyamide-dihydrotestosterone conjugate 
 Dihydrotestosterone (DHT), a steroid hormone, has been used to target prostate 
cancer cells for uptake.30  Based on this, and pursuant to an ongoing collaboration with 
ZhengxinWang’s lab at the University of Texas Southwestern Medical Center (see 
chapter 5), compound 50 was synthesized (Figure 3.18).  This fluorescent compound 
incorporates a hydrophilic polyethylene glycol (PEG) linking domain between the 
polyamide and steroid moieties.  It was hoped that the increased hydrophilicity of the 
compound, due to the linking domain, and the receptor-targeting ability of the DHT 
domain would afford increased uptake in prostate cancer cell lines PC3 and LNCaP.  
Indeed, a comparison of the uptake of 2 with 50 shows marked increase in cytoplasmic 
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staining in PC3 and LNCaP cells.  However, no nuclear staining is detected, suggesting 
that the novel domains do act to increase the transit of the polyamide across the cellular 
membrane, but are unable to overcome the sequestration of compound in cytoplasmic 
vesicles. 
Figure 3.17  Synthesis of CHL conjugates.  (a): (i) 20% piperidine/DMF (v/v), 30 min 
at room temperature.  (ii) Boc2O, DIEA, DMF.  (iii) 3-dimethylaminopropylamine, 6 
hrs at 37ºC.  (iv) Bodipy-FL, HOBt, DCC, DIEA, DMF.  (v) 20% TFA in CH2Cl2
(v/v), 30 min at room temperature.  (vi) 35, HOBt, DCC, DIEA, DMF.  (b): (i) 47, 18 
hrs at 37ºC.  (ii) 35, HOBt, DCC, DIEA, DMF.  (iii) THF, PPh3, 3 hrs at room 
temperature.  (iv) NaOH(aq) 1 eq, 2 hrs at 70ºC.  (v) Bodipy-FL, HOBt, DCC, DIEA, 
DMF.  (vi) BF3·(Et2O)2, CH2Cl2, 30 min at room temperature. 
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Figure 3.18  Synthesis of DHT conjugate.  (i) 20% piperidine/DMF (v/v), 30 min at 
room temperature.  (ii) Boc2O, DIEA, DMF.  (iii) 3-dimethylaminopropylamine, 6 hrs 
at 37ºC.  (iv) 51 (for synthesis, see chapter 5, compound 13), HOBt, DCC, DIEA, 
DMF.  (v) 20% TFA in CH2Cl2 (v/v), 30 min at room temperature.  (vi) Bodipy-FL, 
HOBt, DCC, DIEA, DMF. 
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Experimental Section 
Synthesis of Polyamide Conjugates 1-18, 36-40 
 These conjugates were synthesized by P. S. Arora and J. M. Belitsky.25,37   
 
Synthesis of 2638 
 Maleimide (1 g, 10 mmol), methyl chloroformate (0.8 mL, 10 mmol), and N-
methylmorpholine (1.13 mL, 10 mmol) were dissolved in EtOAc (50 mL) at 0ºC and 
stirred for 1 hr.  The resulting white precipitate was removed by filtration and the filtrate 
concentrated to obtain a pink solid.  Boc- (D) Lys-OH (0.9 g, 3.5 mmol) was dissolved in 
sat. NaHCO3 solution (35 mL) at 0ºC, to which was added the pink solid and the resulting 
suspension was stirred for 4 hrs, with slow warming to room temperature.  The solution 
was extracted with CHCl3 (2 x 150 mL), and the aqueous layer was acidified to pH~3 
with concentrated H2SO4.  The solution was washed with CHCl3 (3 x 100 mL).  The 
organic fractions were combined, dried with MgSO4, and concentrated to yield a 
translucent yellow oil. 
 
Synthesis of Peptide-Polyamide-Bodipy Conjugates 19-24 
 The synthesis of the 1-[3-(tert-butoxycarbonyl)amino]propyl-imidazole-2-
carboxylic acid monomer utilized in the synthesis of 19-24 has been recorded.29  
Polyamide was synthesized on Kaiser oxime resin by standard solid phase methods as 
previously reported and liberated upon treatment with methylamine to provide 25.27,28  26 
(230 µmol) was dissolved in 300 µL DMF, to which was added DCC (230 µmol, 100 µL 
DMF) and HOBt (230 µmol, 100 µL DMF), and the resulting solution allowed to react at 
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37ºC for 30 min.  This solution was added to 25 (70 µmol), dissolved in DMF (500 µL) 
and DIEA (40 µL, 230 µmol), and allowed to react at room temperature for 3 hrs, until 
complete as monitored by analytical HPLC.  The crude product was dissolved into ~10 
mL CH2Cl2, to which was added ~10 mL TFA and the resulting solution stirred at room 
temperature for 30 min.  The solution was concentrated, purified by C18 reverse-phase 
preparatory HPLC, and lyophilized to yield a white powder.  To 10 µmol of this 
polyamide dissolved in DMF (185 µL), was added first a solution of Bodipy-FL (20 
µmol), DCC (20 µmol), and HOBt (20 µmol) dissolved in 300 µL DMF allowed to react 
at room temperature for 30 min, then DIEA (3.5 µL, 20 µmol), and the resulting solution 
was allowed to react at room temperature for 3 hrs.  To 100 µL of this solution was added 
a solution of the appropriate peptide bearing an N-terminal cysteine residue (5 µmol) and 
TCEP (7.5 µmol) dissolved in 6M Gn·HCl (100 µL, pH = 7.3).  The resulting solution 
was allowed to react at room temperature for 1 hr, and then purified by C18 reverse-phase 
preparatory HPLC and lyophilized to yield 19-24 as orange powders.  Characterization:  
19 [(D) C-TAT*-PA-Bodipy], MALDI-TOF [M+H]+ (monoisotopic mass) calcd 2913.9, 
obsd 2914.4;  20 [(L) C-NLS-PA-Bodipy], MALDI-TOF [M+H]+ (monoisotopic mass) 
calcd 2594.2, obsd 2594.4;  21 [(L) C-TAT-PA-Bodipy], MALDI-TOF [M+H]+ 
(monoisotopic mass) calcd 3270.0, obsd 3270.6;  22 [(D) C-R7-PA-Bodipy], MALDI-
TOF [M+H]+ (monoisotopic mass) calcd 2821.4, obsd 2821.7;  23 [(D) C-R9-PA-
Bodipy], MALDI-TOF [M+H]+ (monoisotopic mass) calcd 3132.5, obsd 3132.9;  24 [(D) 
C-(RAhx)6R-PA-Bodipy], MALDI-TOF [M+H]+ (monoisotopic mass) calcd 3500.3, 
obsd 3500.4. 
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Synthesis of Polyamide-Peptide Conjugates 27-32 
 25 (35 µmol) was dissolved in 600 µL DMF and treated with DIEA (59 µL, 350 
µmol) and a solution of 3-maleimidopropionic acid (0.028 g, 175 µmol), DCC (0.035 g, 
165 µmol) and HOBt (0.024 g, 175 µmol) reacted for 30 min at room temperature in 200 
µL DMF.  The resulting solution was allowed to react at room temperature for 3 hrs then 
purified by C18 reverse-phase preparatory HPLC and lyophilized to yield a white powder.  
The maleimido-polyamide (2 µmol) was dissolved in 160 µL DMF, to which was added 
a solution of TCEP (4 µmol) and peptide (10 µmol) in 200 µL Gn·HCl (6 M, pH = 7.3).  
The resulting solution was allowed to react at room temperature for 1 hr, and then 
purified by C18 reverse-phase preparatory HPLC and lyophilized to yield 27-32 as white 
powders.  Characterization:  27 [(L) C-NLS-PA], MALDI-TOF [M+H]+ (monoisotopic 
mass) calcd 2261.4, obsd 2261.1;  28 [(L) C-TAT-PA], MALDI-TOF [M+H]+ 
(monoisotopic mass) calcd 2936.1, obsd 2935.5;  29 [(D) C-TAT*-PA], MALDI-TOF 
[M+H]+ (monoisotopic mass) calcd 2582.1, obsd 2581.8;  30 [(D) C-R7-PA], MALDI-
TOF [M+H]+ (monoisotopic mass) calcd 2489.3, obsd 2489.2;  31 [(D) C-R9-PA], 
MALDI-TOF [M+H]+ (monoisotopic mass) calcd 2801.4, obsd 2801.1;  32 [(D) C-
(RAhx)6R-PA], MALDI-TOF [M+H]+ (monoisotopic mass) calcd 3168.0, obsd 3166.8. 
 
Synthesis of Polyamide-Disulfide-Peptide Conjugates 33-34 
 Polyamide was synthesized on Kaiser oxime resin employing the 1-[3-
(fluorenylmethyloxycarbonyl)amino]propyl-4-(tert-butoxycarbonyl)amino-pyrrole-2-
carboxylic acid monomer, whose synthesis has been detailed elsewhere.29  The Fmoc 
protecting group was removed upon treatment of the resin with 20% (v/v) 
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piperidine/DMF, and replaced with the t-Boc protecting group by treatment of the resin 
with Boc2O (0.5 g, 2.3 mmol) and DIEA (400 µL, 2.3 mmol) in 4 mL NMP.  The 
polyamide was liberated from resin by treatment with 3,3’-diamino-N-
methyldipropylamine for 10 hrs at room temperature and purified by C18 reverse-phase 
preparatory HPLC and lyophilized to yield 35 as a white powder. 
 S-trityl-3-mercaptopropionic acid (0.026 g, 75 µmol), DCC (75 µmol), and HOBt 
(75 µmol) were dissolved in 225 µL DMF and allowed to activate for 3 hrs at room 
temperature.  The resulting solution was centrifuged to remove precipitated DCU and 
added to a solution of 35 (11 µmol), dissolved in 300 µL DMF, and DIEA (15 µL, 90 
µmol) was added.  This was allowed to react for 18 hrs at room temperature.  Dp (8 µL) 
was added (to quench any remaining S-trityl-3-mercaptopropionic acid –OBt ester), then 
the crude product was precipitated by addition of Et2O and treated with 50% (v/v) TFA in 
CH2Cl2 for 1 hr at room temperature.  The resulting solution was purified by C18 reverse-
phase preparatory HPLC and lyophilized to yield 36 as a white powder. 
 A solution of Bodipy-FL (17 µmol), DCC (17 µmol), and HOBt (17 µmol) was 
prepared in 200 µL DMF and allowed to activate for 2 hrs at room temperature.  This was 
added to a solution of 36 (9 µmol) in DMF (300 µL) and DIEA (10 µL, 60 µmol) and 
allowed to react at room temperature for 1 hr.  This solution was purified by C18 reverse-
phase preparatory HPLC and lyophilized to yield 37 and the thioester of 37 and Bodipy 
(1:1) as orange powders.  The thioester was treated with 10 µL Dp to cleave the Bodipy 
thioester and purified to yield 37. 
 Each peptide (2 µmol) was dissolved in 75 µL DMF.  2-Aldrithiol (0.5 µmol) was 
added and the solutions allowed to react for 1 min.  A solution of 37 in 75 µL DMF was 
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then added to each peptide solution and allowed to react for 4 hrs.  They were then 
purified by C18 reverse-phase preparatory HPLC and lyophilized to yield 33 and 34 as 
orange powders.  Characterization:  33 [(D) C-TAT*-SS-PA], MALDI-TOF [M+H]+ 
(monoisotopic mass) calcd 2905.4, obsd 2907.8;  34 [(D) C-R9-PA], MALDI-TOF 
[M+H]+ (monoisotopic mass) calcd 3124.7, obsd 3126.3. 
 
Synthesis of Bodipy-Polyamide-Chlorambucil Conjugate (42) 
Polyamide was synthesized on Boc-β-Ala-PAM resin employing the 1-[3-
phthalimido)amino]propyl-4-(tert-butoxycarbonyl)amino-pyrrole-2-carboxylic acid 
monomer, whose synthesis has been reported elsewhere.39  The Fmoc protecting group on 
the DABA turn was removed upon treatment of the resin with 20% (v/v) 
piperidine/DMF, and replaced with the t-Boc protecting group by treatment of the resin 
with Boc2O (0.64 g, 3.0 mmol) and DIEA (200 µL, 1.7 mmol) in 3 mL DMF.  The 
polyamide was liberated from resin by treatment with Dp for 18 hrs at 37ºC and purified 
by C18 reverse-phase preparatory HPLC and lyophilized to yield 44 as a white powder. 
A solution of Bodipy-FL (22 µmol), DCC (22 µmol), and HOBt (22 µmol) was 
prepared in 265 µL DMF and allowed to activate for 1 hr at room temperature.  To this 
was added a solution of 44 (11 µmol) and DIEA (6 µL, 34 µmol), and the resulting 
solution was allowed to react at room temperature for 10 hrs.  The crude product was 
precipitated by addition of Et2O and treated with 20% (v/v) TFA in CH2Cl2 for 30 min at 
room temperature.  The resulting solution was purified by C18 reverse-phase preparatory 
HPLC and lyophilized to yield 45 as an orange powder. 
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A solution of chlorambucil (0.009 g, 30 µmol), DCC (30 µmol), and HOBt (30 
µmol) was prepared in 200 µL DMF and allowed to activate for 1 hr at room 
temperature.  To the resulting solution was added a solution of 45 (3 µmol) in 350 µL 
DMF and DIEA (2 µL, 10 µmol), which was allowed to react for 3 hrs at room 
temperature, then purified by C18 reverse-phase preparatory HPLC and lyophilized to 
provide 42 as an orange powder.  Characterization:  ESI peaks of [M+H]+ (monoisotopic 
mass 35Cl) calcd 1840.9, obsd 1841.1; [M+H]+ (isotopic mix of one 35Cl and one 36Cl) 
calcd 1841.9, obsd 1842.4; [M+H]+ (monoisotopic mass 36Cl) calcd 1842.9, obsd 1843.3. 
 
Synthesis of Bodipy-Polyamide-Chlorambucil Conjugate (43) 
 Polyamide was synthesized on Kaiser oxime resin using azide pyrrole monomer 
46 and liberated by cleavage with 47 (~1g, ~4 mmol) in 1 mL NMP.  This solution was 
purified by C18 reverse-phase preparatory HPLC and lyophilized to provide polyamide as 
a white powder.  The polyamide (8.8 µmol) was treated with an activated solution of 
chlorambucil (45 µmol), DCC (45 µmol), and HOBt (45µmol), as well as with DIEA (15 
µL, 90 µmol).  The resulting solution was allowed to react at room temperature for 3 hrs, 
then the crude product 48 was precipitated by addition of Et2O. 
 Solutions of 48 (4.5 µmol) and triphenylphosphine (4.5 µmol) were prepared in 
anhydrous THF, then mixed and allowed to react for 3 hrs at room temperature.  To this 
was then added aqueous NaOH (4.5 µmol) and the resulting solution heated at 70ºC for 2 
hrs, until complete by analytical HPLC.  The crude product 49 was precipitated by 
addition of Et2O, then treated with an activated solution of Bodipy-FL (11 µmol), DCC 
(11 µmol), and HOBt (11 µmol), and DIEA (15 µL, 11 µmol).  The crude product was 
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precipitated by addition of Et2O, then resuspended in 100 µL anhydrous CH2Cl2, to 
which was added 10 µL BF3·(Et2O)2 and the solution allowed to react at room 
temperature for 30 min.  The crude conjugate was precipitated upon addition of Et2O and 
purified by C18 reverse-phase preparatory HPLC and lyophilized to provide 43 as an 
orange powder.  Characterization:  ESI peaks of [M+H]+ (monoisotopic mass 35Cl) calcd 
1812.9, obsd 1812.5; [M+H]+ (isotopic mix of one 35Cl and one 36Cl) calcd 1813.9, obsd 
1813.5; [M+H]+ (monoisotopic mass 36Cl) calcd 1814.9, obsd 1814.6. 
  
Synthesis of 1-[3-(azido)propyl]-4-(tert-butoxycarbonyl)amino-pyrrole 2-carboxylic 
acid (46) 
 Ethyl-4-nitropyrrole-2-carboxylate (2.5g, 13 mmol) was dissolved in acetone, to 
which was added K2CO3, and the resulting suspension stirred vigorously at room 
temperature for 2 hrs.  To this was added 3-iodopropanol (2.6 mL, 26 mmol), then the 
suspension was stirred vigorously under reflux for 2 hrs, 30 min.  The slurry was cooled 
to room temperature, filtered, and concentrated to yield a yellow oil.  To this was added 
100 mL H2O and the pH was adjusted to ~3 with 10% (v/v) H2SO4.  The mixture was 
extracted with EtOAc (3 x 100 mL), dried (MgSO4), concentrated, and purified on silica 
with 2:1 hexanes:EtOAc to yield a clear oil (3.6 g, 56% yield). 
 The ethyl-1-(3-hydroxyl)propyl-4-nitropyrrole-2-carboxylate (1.6 g, 6.8 mmol) 
was dissolved in 20 mL EtOAc, to which was added 10% (wt/wt) Pd/C (0.3 g, 0.28 
mmol).  The suspension was added to a Parr bomb, pressurized to 100 psi H2, and stirred 
at room temperature for 2h.  The mixture was filtered through celite to remove the Pd/C 
and concentrated.  The resulting yellow oil was dissolved in 20 mL DMF, to which was 
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added DIEA (2.44 mL, 14 mmol) and Boc2O (1.53 g, 7 mmol), and stirred at room 
temperature for 2 hrs.  The solution was concentrated and purified on 75g silica with 1:1 
hexanes:EtOAc to yield a clear oil (1.77g, 84% yield). 
 This oil (1g, 3.2 mmol) was dissolved in 10 mL CH2Cl2, to which was added 
triethylamine (0.67 mL, 4.9 mmol), and the resulting solution was cooled to 0ºC.  The 
solution was then treated with mesyl chloride (0.33 mL, 4.2 mmol) and DMAP (0.16 g, 
1.3 mmol), stirred at 0ºC for 15 min, then allowed to warm to room temperature while 
stirring for 1 hr.  40 mL CH2Cl2 was added and the solution was washed with 1M 
KHSO4, H2O, sat. NaHCO3, H2O, and brine (50 mL each), dried (MgSO4), and 
concentrated.   
The resulting oil was dissolved in DMF (10 mL), to which was added NaN3 (1g, 
16 mmol) and the resulting solution stirred at 55ºC under Ar for 1 hr 30 min.  The 
solution was partitioned between 50 mL brine and 50 mL Et2O.  The aqueous layer was 
washed with an additional 30 mL Et2O.  The organic portions were combined and washed 
with 10% (v/v) citric acid, brine, 1M NaHCO3, and brine (2 x 20 mL each), dried, and 
concentrated to a yellow oil.  The oil was dissolved in 10 mL EtOH, to which was added 
5 mL KOH, and stirred at 40ºC for 6 hrs.  The solution was cooled to room temperature 
and acidified with 10% (v/v) H2SO4 to pH~3.  The mixture was extracted with CH2Cl2 (3 
x 40 mL), washed with brine, dried (MgSO4), and concentrated to yield 46 as a pale 
yellow solid.  1H NMR (300 mHz, CDCl3): δ 7.25 (s, 1 H), 6.66 (s, 1 H), 4.40 (t, 2 H), 
3.53 (t, 2 H), 1.96 (m), 1.50 (s, 9 H).  
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Synthesis of 3-(tert-butoxycarbonyl), 3’-diamino-N-methyldipropylamine (47) 
 3,3’-diamino-N-methyldipropylamine (32.2 mL, 200 mmol) was cooled to 0ºC.  A 
solution of Boc2O (4.4g, 20 mmol) was prepared in CH2Cl2 and added to cooled amine 
dropwise while stirring for 30 min.  The solution was allowed to cool to room 
temperature while stirring for 1 hr 30 min.  The solution was then extracted with 200 mL 
¼ sat. NaHCO3 (a volume of sat. NaHCO3 diluted to 25% concentration).  The aqueous 
solution was back-extracted with CH2Cl2 (4 x 50 mL), and the organic portions combined 
and washed with 50 mL sat. NaHCO3 and 50 mL brine.  The solution was dried with 
MgSO4 and concentrated to yield a pearly-white oil, which was azeotroped with toluene 
(2.5 g, 55% yield).  1H NMR (300 mHz, CDCl3): δ 3.19 (br. q, 2 H), 2.81 (t, 2 H), 2.38 
(m, 4 H), 1.65 (m, 4 H), 1.43 (s, 9 H). 
 
Synthesis of Bodipy-Polyamide-DHT Conjugate (50) 
 Polyamide 44 was prepared as above.  DHT-linker molecule 51 was prepared as 
detailed in Chapter 5.  A solution of 51 (17 µmol), DCC (17 µmol), and HOBt (17 µmol) 
was prepared and allowed to react at room temperature for 30 min.  To this was added a 
solution of 44 (3 µmol) and DIEA (1.6 µL, 10 µmol), and the resulting solution was 
allowed to react at room temperature for 2hrs.  Dp (4 µL) was added to quench excess 
activated acid and the solution was concentrated with speedvac for 1 hr.  The 
concentrated oil was treated with 1 mL 80% (v/v) TFA in CH2Cl2 for 2 hrs at room 
temperature, then was azeotroped with benzene 3x.  The resulting oil was purified by C18 
reverse-phase preparatory HPLC and lyophilized to yield DHT-polyamide as a white 
powder. 
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 A solution of Bodipy-FL (3.6 µmol), DCC (3.6 µmol), and HOBt (3.6 µmol) was 
prepared and allowed to react for 30 min.  To it was added the DHT-polyamide (1.8 
µmol) and DIEA (0.5 µL, 5 µmol), and the resulting solution was allowed to react at 
37ºC for 16 hrs.  The solution was purified by C8 reverse-phase preparatory HPLC and 
lyophilized to yield 50 as an orange powder.  Characterization:  MALDI-TOF [M+H]+ 
(monoisotopic mass) calcd 2017.0, obsd 2017.8. 
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Chapter 4A 
Polyamide-FITC Conjugates for Cellular Uptake Studies 
Abstract 
A series of hairpin pyrrole-imidazole polyamide-fluorescein conjugates were 
synthesized and assayed for cellular localization.  Thirteen cell lines, representing eleven 
human cancers, one human transformed kidney cell line, and one murine leukemia cell 
line, were treated with 5 µM polyamide-fluorescein conjugates for 10-14 hrs, then 
imaged by confocal laser scanning microscopy.  A conjugate containing a β-alanine 
residue at the C-terminus of the polyamide moiety showed no nuclear localization, while 
an analogous compound lacking the β-alanine residue was strongly localized in the nuclei 
of all cell lines tested.  The localization profiles of several other conjugates suggest that 
pyrrole-imidazole sequence and content, dye choice and position, linker composition, and 
molecular weight are determinants of nuclear localization.  The attachment of fluorescein 
to the C-terminus of a hairpin polyamide results in an approximate 10-fold reduction in 
DNA-binding affinity, with no loss of binding specificity with reference to mismatch 
binding sites. 
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Introduction 
Small molecules that preferentially bind to predetermined DNA sequences inside 
living cells would be useful tools in molecular biology, and perhaps human medicine.  
The effectiveness of these small molecules requires not only that they bind to 
chromosomal DNA site-specifically, but also that they be permeable to the outer 
membrane and gain access to the nucleus of living cells.  Polyamides containing the 
aromatic amino acids N-methylpyrrole (Py), N-methylimidazole (Im) and N-methyl-3-
hydroxypyrrole (Hp) bind DNA with affinities and specificities comparable to naturally 
occurring DNA-binding proteins.1,2 A set of pairing rules describes the interactions 
between pairs of these heterocyclic rings and Watson-Crick base pairs within the minor 
groove: Im/Py is specific for G•C, Hp/Py is specific for T•A and Py/Py binds both A•T 
and T•A.  Exploitation of polyamides to target sequences of biological interest has 
yielded results in a number of cell-free systems.3-8 
Extension of these in vitro biological results to cellular systems has proven to be 
cell-type dependent.  Polyamides exhibited biological effects in primary human 
lymphocytes,9 human cultured cell lines,10 and when fed to Drosophila embryos.11,12  
However, attempts to inhibit the transcription of endogenous genes in cell lines other than 
insect or T-lymphocytes have met with little success.  For example, polyamides that 
down-regulate transcription of the HER2/neu gene in cell-free experiments display no 
activity in HER2-overexpressing SK-BR-3 cells.13 
To determine if these results were due to poor cellular uptake or nuclear 
localization, a series of polyamides incorporating the fluorophore Bodipy FL was 
synthesized.  Intracellular distribution of these molecules in several cell lines was then 
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determined by confocal laser scanning microscopy.14  Cells which demonstrated robust 
responses to polyamides, such as T-lymphocyte derivatives, showed staining throughout 
the cells, including the nucleus.  In other cell lines studied, however, treatment with 
polyamide-Bodipy conjugates produced a punctate staining pattern in the cytoplasm, with 
no observable signal in the nuclei.  Bashkin and coworkers recently reported that an 
eight-ring polyamide-Bodipy conjugate colocalized with LysoTracker Red DND 99 (a 
lysosome and trans-Golgi stain, 23) in several cell lines, indicating that the punctate 
staining pattern was presumably due to trapping of the polyamide in acidic vesicles.15  In 
contrast, an eight-ring polyamide-fluorescein conjugate, 1, was shown to accumulate in 
the nuclei of HCT-116 human colon cancer cells. 
  We have found that a similar eight-ring polyamide-fluorescein conjugate, 2, with 
a single Py to Im change, is excluded from the nuclei of thirteen different mammalian cell 
lines, whereas removal of the β-Ala residue in the linker, affording 3, enables nuclear 
localization in all of these cell lines, with no obvious toxicity.  This raises the issue: what 
are the molecular determinants—fluorophore, position of attachment, linker composition, 
polyamide sequence and size—of uptake and nuclear localization in cultured cells? 
Understanding nuclear accessibility in a wide variety of living cells is a minimum first 
step toward chemical regulation of gene expression with this class of molecules.  A 
further issue will be whether polyamides modified for optimal cellular and nuclear uptake 
retain favorable DNA-binding affinity and sequence specificity.  We have synthesized 
twenty-two polyamide-fluorophore conjugates with incremental changes in structure and 
examined their intracellular distribution in thirteen cell lines. 
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Results 
Structures for all of the compounds synthesized are listed in Figure 4.1.  Sample 
images for compounds 2 and 3 in two cell lines are shown in Figure 4.2a.  To show that 
compound 3 localizes to the nuclei of live cells, samples were treated with 3, the nuclear 
stain Hoechst 33342, and the dead-cell stain Sytox Orange (Figure 4.2b).  The uptake 
characteristics of compounds 1-22 were examined in thirteen cell lines by confocal 
microscopy, and each sample was rated qualitatively for the extent of nuclear localization 
(Figure 4.3). 
The molecules showing the highest degree of nuclear uptake in most cell lines 
stained nuclei very brightly with reference to the background fluorescence caused by 
fluorescent agent in the medium.  Agents 1, 3, 5, 6, 11-14, and 22 showed such high 
levels of uptake in many cell lines.  Many compounds exhibited a very scattered uptake 
profile in the series of cells studied, and compounds 2, 4, 15, and 21, showed no 
significant nuclear staining in any cell line.  Of the entries in Figure 4.3 indicating poor 
nuclear uptake properties, most reflect lysosomal staining, as indicated by costaining with 
LysoTracker Red DND-99, as well as fluoresence in the intercellular medium.  Only 
compound 2 was found exclusively in the medium, showing no uptake in cells. 
The DNA-binding properties of 3 were assessed by DNase I footprinting titrations 
on the plasmid pDEH9, which bears the 5'-TGGTCA-3' match site and discrete single 
base-pair mismatch sites.  Conjugate 3 bound to the match site with a Ka of 1.6 (± 0.3) x 
109 M-1, and showed specificity over mismatch sites by >100-fold (Figure 4.4). 
 To investigate the energy dependence of the cellular uptake mechanism of 
compound 3, HeLa cells growing under normal conditions were incubated for 30 min in  
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Figure 4.1  Structures of compounds used in uptake experiments. 
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Figure 4.2  Cellular localization of polyamide-fluorescein conjugates.   (a) (Top) 
Adherent MCF-7 cells were treated with compound 2 (Upper left) or 3 (Upper right) 
for 10-14 h at 5 µM.   Compound 2 was excluded from the cells entirely, while 
compound 3 localized to the nucleus.   (Bottom) Suspended Jurkat cells were similarly 
treated, and show similar results.   (b) Colocalization of polyamide 3 and Hoechst in 
live cells, imaged using sequential single- and two-photon excitation.   (Top) MCF-7 
cells were treated with the nuclear stain Hoechst 33342 (15 µM), compound 3 (5 µM), 
and the dead cell stain Sytox Orange (0.5 µM).   Fluorescence signals from Hoechst 
(Upper left, blue) and compound 3 (Upper center, green) colocalize in cell nuclei. 
(Upper right)  Overlay of the visible light image (grayscale) and the Sytox Orange 
fluorescence image (red), indicating that the majority of cells are alive.  (Bottom) 
Jurkat cells were treated similarly, and show similar results.  (Scale bar = 10 µm.) 
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Figure 4.3  Uptake profile of compounds 1-22 in 13 cell lines: “+ +” Indicates nuclear 
staining exceeds that of the medium; “+” indicates nuclear staining ≤ that of the 
medium, but still prominent; “-” indicates very little nuclear staining, with the most 
fluorescence seen in the cytoplasm and/or medium; “--” indicates no nuclear staining. 
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Figure 4.4  Quantitative DNase I footprinting titration.   (a) Compound 3 binds the 3'-
TGGTCA-5' site with an affinity Ka = 1.6 (± 0.3) x 109 M-1.  Compound 3 does not 
bind the single base-pair mismatch sites shown at concentrations ≤ 200 nM.   (b) DNA 
binding isotherm for compound 3. 
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either normal DMEM medium or inhibitory DMEM medium, then treated with 3 for 1 hr 
prior to confocal imaging (Figure 4.5).  The cells growing in normal medium showed 
clear nuclear staining, whereas the cells growing in inhibitory medium displayed very 
little to no discernable staining.  Subsequent washing and replacement of the inhibitory 
medium with normal medium (supplemented with 5 µM 3), resulted in nuclear staining 
after 1 h, comparable to that seen in the sample grown continuously in the normal 
medium. 
 It had been shown previously that polyamide-Bodipy conjugates stain the nuclei 
of T-lymphocytes, but no other cell type tested, and most commonly produced a punctate 
cytoplasmic staining pattern.14 Our studies indicated that a polyamide-fluorescein 
conjugate, 2, uniformly proved refractory to nuclear uptake in several human cancer cell 
lines.  Elimination of the β-alanine residue at the carboxy-terminal end of the polyamide 
afforded compound 3, which, surprisingly, showed excellent nuclear staining properties 
in the cell lines examined.  Attachment of the Bodipy-FL fluorophore to the polyamide 
precursor of compound 3 provided compound 4.  This molecule showed no nuclear 
staining, sequestering itself in cytoplasmic vesicles, indicating that some characteristic of 
polyamide-Bodipy conjugates differing from that of polyamide-FITC conjugates, and not 
the C-terminal β-alanine, prevents their trafficking into the nucleus.  It is interesting to 
note that the structure of LysoTracker Red DND-99 (23) includes both a tertiary alkyl 
amine, similar to that often used in hairpin polyamide tails, and a Bodipy moiety. 
It became our intent to explore the structure-space of polyamide-fluorophore 
conjugates to overcome cellular exclusion and lysosomal trapping, allowing the 
polyamides to travel to the nucleus.  To explore the criteria that permit uptake of 3, and  
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Figure 4.5  Energy dependence of nuclear localization of compound 3.   (a) HeLa 
cells were washed, incubated in normal DMEM medium for 30 min, supplemented 
with 5 mM 3, incubated for 1 h, and imaged, showing roughly equivalent amounts of 
compound localized both in the nucleus and in the medium (left).   The cells were 
incubated for a further 1 h 30 min, and then imaged once more (right), showing 
exclusively nuclear localization.   (b) HeLa cells were washed, incubated in inhibitory 
DMEM medium for 30 min, supplemented with 5 mM 3, incubated for 1 h, and 
imaged, showing localization at the cellular membranes, as well as in the medium 
(left).   The cells were incubated for a further 1 h 30 min, and then imaged once more 
(right), showing exclusively membranous localization.   (c) Recovery experiment: 
HeLa cells treated as in b were washed 2x with normal DMEM medium, incubated for 
1h 30 min in normal DMEM medium supplemented with 5 mM 3, then imaged, 
showing recovery of nuclear localization upon replacement of inhibitory medium with 
normal medium.   (Scale bar = 10 µm.) 
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that prevent that of 4, several variations on the structure of the compound were made and 
their effects determined by confocal microscopy. 
Wishing to explore the effect of Py/Im sequence and content of hairpin 
polyamides on cellular trafficking, we synthesized compounds 5-8.  Compounds 5 and 6, 
both containing two imidazole residues, showed a high degree of nuclear staining in all 
cell lines studied.  Three-imidazole compound 7 showed intermediate levels of nuclear 
staining in the cell lines studied.  The nuclear localization of four-imidazole compound 8 
was quite poor in all cell lines tested.  The difference in nuclear staining levels exhibited 
by compounds 3 and 7 shows that Py/Im sequence alone is an important determinant of 
nuclear uptake, though overall content (in terms of the number of Py and Im residues) 
may also be a factor. 
To explore the effect of the positively-charged linker on nuclear uptake, 
compound 9 was synthesized.  This agent showed nearly global abrogation of nuclear 
uptake efficiency versus the analog containing a tertiary amine.  Further, substitution of 
the γ-aminobutyric acid turn (γ-turn) of 9 with the [(R)-α-amino]-γ-diaminobutyric acid 
turn (H2Nγ-turn) provided 10, which restored most of the nuclear uptake properties of 3.  
This suggests that the overall charge of the molecule, and perhaps the placement of that 
charge, are important variables in nuclear uptake of polyamide-dye conjugates. 
The H2Nγ-turn is a structural element commonly included in polyamide design.  
Replacement of the γ-turn of 3 with the H2Nγ-turn provided 11.  This molecule showed 
nuclear staining in all cell lines tested, save NB4, though often to a lesser degree than 3.  
It is unclear whether this reduction in uptake efficiency is due to an increase in the overall 
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positive charge of the molecule, a more branched structure than the linear γ-linked 
hairpin, or the positioning of a positive charge medial in the molecule. 
Selective acetylation of the polyamide precursor to 11, followed by FITC 
conjugation, provided 12.  This molecule exhibited excellent nuclear uptake, as good or 
better than both 11 and 3.  The excellent uptake of 12 argues against branching as a 
negative determinant of nuclear staining.  This result also prompted us to synthesize 13-
15 to probe the generality and flexibility of turn acetylation across several polyamide 
sequences.  The uptake of 13 and 14 was mostly nuclear.  Compound 15, on the other 
hand, was a very poor nuclear stain.  This result reaffirms the importance of polyamide 
sequence on nuclear uptake. 
We next synthesized several conjugates to explore the uptake effects of different 
points of attachment of the fluorophore-linker moiety to the polyamide.  An N-
propylamine linkage from the terminal imidazole and a methylamide tail were 
incorporated into 16, which showed poor nuclear uptake in nearly all cell lines tested.  
We thought it possible that the poor uptake properties of conjugate 16 was due to some 
non-linearity introduced into the overall structure of the molecule by the linkage at the 1-
position of the N-terminal ring of the polyamide.  Consequently, conjugates 17 and 18 
were synthesized, appending the linker-fluorophore moiety to the N-terminal amine.  
Although compound 17 has an overall structure and charge distribution very similar to 
that of 9, it possesses better nuclear uptake properties, particularly in suspended cell lines.  
Subsequent addition of a positive charge at the C-terminal end of the polyamide through 
employment of an N,N-dimethylaminopropylamine tail (compound 18) boosts uptake in 
all cell lines studied, save NB4.  Once again, this suggests that the addition or deletion of 
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a single charge may (but not necessarily will) have a strong effect on nuclear uptake.  In 
fact, a comparison of compounds 3, 10, and 18 (differing in the placement of a positive 
charge) with 9 and 17 (which lack a positive charge) seems to indicate that the 
positioning of this charge is less influential than its presence. 
Another common structural feature utilized in DNA-binding polyamides is the 
addition of one or more β-alanine residues.  This amino acid is often used to relax 
overcurvature of a polyamide backbone with reference to the minor groove of DNA and 
permits the targeting of longer sequences than that of eight-ring hairpins.  Compound 19, 
which includes this structural element, and 20, which includes both β-alanines and the 
H2Nγ-turn, showed fair to poor nuclear uptake in the cell line series.  The reduced uptake 
levels could be due to the increased molecular flexibility imparted by the β-alanine 
residues, increased molecular weight, decreased recognition by a cellular import protein, 
or some combination of these criteria. 
In order to determine whether or not the added size imparted to 19 and 20 by the 
β-alanine residues was likely a major contributor to their poor uptake, the ten-ring 
compound 21 was synthesized.  Its ubiquitously poor nuclear uptake suggests that 
molecular weight may, indeed, play a prominent role in uptake character.  The excellent 
uptake character of the six-ring compound 22 furthers this hypothesis, though Py/Im 
sequence in the 6-ring and 10-ring contexts is also likely to be important. 
This study demonstrates the cellular localization profile of a host of polyamide-
dye conjugates in a wide variety of cell lines.  In general, compounds exhibiting good 
nuclear uptake properties have several common elements: an eight-ring polyamide DNA-
binding domain, one or more positive charges incorporated within either the linker or the 
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turn residue, and a conjugated fluorescein fluorophore.  This study also demonstrates that 
each cell line possesses a unique uptake profile for the panel of compounds presented to 
it.  These profiles will be important in choosing a cell line and compound architecture 
appropriate to a given experiment. 
Conjugation of the fluorophore to the polyamide DNA-recognition domain results 
in an approximately 10-fold reduction in DNA-binding affinity as compared with the 
parent polyamide, with retention of binding specificity over mismatch sites.  This quality, 
along with the nuclear uptake results, suggests that fluorophore-conjugated polyamides 
may be employed directly in experiments designed to take place in living mammalian 
cells. 
Clearly, there are many criteria at work, each one having its share of influence 
upon nuclear uptake of polyamide-dye conjugates.  The extension of the structure-space 
of compounds known to both bind chromosomal DNA specifically and with high affinity, 
as well as to traffic to the nucleus of living cells is the object of current investigations.  
The illumination of these possibilities will permit the further study of transcriptional 
regulation in living systems. 
 
Experimental 
Chemicals 
 Polyamides 1 and 2 were prepared by solid-phase methods on Boc-β-alanine-
PAM-resin (Peptides International; Louisville, KY).16  All other polyamides were 
synthesized by solid phase methods on the Kaiser oxime resin (Nova Biochem; 
Laufelfingen, Switzerland).17  After cleavage with the appropriate amine and reverse-
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phase HPLC purification, polyamides were allowed to react at room temperature for ~3 h 
at ~0.01 M in N,N-dimethylformamide with fluorescein isothiocyanate (FITC; 
compounds 1-3 and 5-22) or the N-hydroxysuccinimidyl ester of BODIPY-FL (4), as 
well as 20 eq of Hünig’s base, to yield polyamide-dye conjugates.  The purity and 
identity of the dye conjugates were verified by analytical HPLC, UV-vis spectroscopy 
and MALDI-TOF mass spectrometry.  All fluorescent dye reagents were from Molecular 
Probes.  Chemicals not otherwise specified were from Aldrich. 
 
Mass Spectra 
MALDI mass spectra were obtained on a Voyager De PRO time-of-flight mass 
spectrometer (Applied BioSystems) operated at an accelerating voltage of +20 kV.   
Samples were applied to the target in an α-cyanohydroxycinnamic acid matrix.   The 
mass spectrometer was calibrated with a calibration mixture provided by the instrument 
manufacturer.  The mass spectra data are summarized in Table 4.1. 
 
Preparation of Polyamide Solutions 
To make 100 µM solutions of each compound, dry HPLC-purified aliquots of 
each conjugate were dissolved to 1-10 mM in DMSO, then diluted with PBS buffer (pH 
7.4) or 18 MΩ cm water to ~200 µM.   A small portion of this solution was diluted to ~10 
µM and the concentration determined by UV quantitation at 310 nm (compounds 1-20: ε 
= 69500;  compound 21: ε = 86875;  compound 22: ε = 52125) the concentrated solution 
was then diluted to 100 µM.   The final concentration of DMSO in any sample was less 
than 1.5%, usually less than 0.1%. 
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Cell Cultures 
The human cancer cell lines DLD-1, MCF-7, 786-O, LNCaP, PC3, MEG-01, 
NB4, Jurkat, and CCRF-CEM were cultured in a 5% CO2 atmosphere at 37°C in 
supplemented RPMI-1640 medium.   The human cancer cell line HeLa, the murine 
leukemia cell line MEL, and the transformed human kidney cell line 293 were grown as 
above in supplemented Dulbecco’s Modified Eagle medium (DMEM).   The human 
cancer cell line SK-BR-3 was cultured as above in supplemented McCoy’s medium.   All 
media were supplemented with 10% fetal bovine serum (Irvine Scientific) and 1% 
penicillin/streptomycin solution (Sigma). 
 
Confocal Microscopy 
Adherent cell lines were trypsinized for 5-10 min at 37°C, centrifuged for 5 min 
at 5°C at 2000 rpm, and resuspended in fresh medium to a concentration of 1.25 x 106 
cells/mL.  Suspended cell lines were centrifuged and resuspended in fresh medium to the 
same concentration.  Incubations were performed by adding 150 µL cells into culture 
dishes equipped with glass bottoms for direct imaging (MatTek Corporation).  Adherent 
cells were grown in the glass-bottom culture dishes for 24 h.  The medium was then 
removed and replaced with 142.5 µL of fresh medium.  Then 7.5 µL of the 100 µM 
polyamide solution was added and the cells were incubated in a 5% CO2 atmosphere at 
37°C for 10-14 h.  Suspended cell line samples were prepared in a similar fashion, 
omitting trypsinization.  These samples were then incubated as above for 10-14 h.  
Imaging was performed with a Zeiss LSM 5 Pascal inverted laser scanning microscope.   
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Images were line-averaged 4, 8, or 16 times and were obtained at a 0.8 µs/pixel scanning 
rate.   Polyamide-fluorescein conjugate fluorescence and visible light images were 
obtained using 488 nm laser excitation with a standard fluorescein filterset and a pinhole 
of 181 µm.   For two-color experiments with LysoTracker Red DND-99, cells were 
treated with 0.75 µL of a 100 µM DMSO stock solution, affording a final dye 
concentration of 500 nM LysoTracker.   After ~10 min incubation with LysoTracker, 
images were obtained by simultaneous 488 nm and 543 nm laser excitation and a filterset 
appropriate for simultaneous visualization of fluorescein and rhodamine. 
Hoechst colocalization experiments were performed on a Zeiss LSM 510 META 
NLO upright laser scanning microscope with a Coherent Chameleon 2-photon laser.   For 
the MCF-7 cell line, the cells were grown in glass-bottom culture dishes in a volume of 
150 µL and treated with polyamide 3 as usual.   Approximately 30 min prior to imaging, 
0.75 µL of Sytox Orange solution (100 µM in DMSO) and 3 µL of Hoechst 33342 
solution (750 µM in sterile water) were added to the cell medium, affording final dye 
concentrations of 500 nM Sytox and 15 µM Hoechst.   Immediately prior to imaging, a 
coverslip was placed over the cells, and the dish inverted.   Three sequential images were 
obtained in succession, at a 0.8 µs/pixel scanning rate.   The images were line-averaged 8 
times.  The Sytox and visible light overlay was collected using 543 nm laser excitation 
with a standard rhodamine filterset and a pinhole of 499 µm.   The polyamide-fluorescein 
conjugate was imaged using 488 nm laser excitation with a standard fluorescein filterset 
and a pinhole of 181 µm.   Hoechst was imaged using 800 nm laser two-photon excitation 
with an HFT KP 680 dichroic and a 390-465 nm bandpass filter with a fully open 
pinhole.    
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For the Jurkat cell line, cells were treated as above, but immediately prior to 
imaging, 30 µL of the cell solution was placed between a clean glass slide and a coverslip 
separated by a coverslip spacer.   Images were collected in multitrack mode, at a 0.64 
µs/pixel scanning rate.   The images were line-averaged 8 times.   Sytox and Hoechst 
were imaged using 800 nm laser two-photon excitation with an HFT KP 680 main 
dichroic, an NFT 545 secondary dichroic, a 565-615 nm bandpass filter for the Sytox 
signal (fully open pinhole), and a 390-465 bandpass filter for the Hoechst signal (363 µm 
pinhole).   The polyamide-fluorescein conjugate and visible light images were obtained 
using 488 nm laser excitation with a standard fluorescein filterset and a pinhole of 249 
µm.    
 
Energy Dependence Experiments 
Inhibitory medium was prepared by supplementing glucose- and sodium 
pyruvate-free DMEM (Gibco #1196025) with 2-deoxyglucose (6 mM) and sodium azide 
(10 mM).18  Cells were grown, trypsinized, resuspended, plated and incubated as above.  
After 24 h of growth at 37°C in 5% CO2, the medium was removed and replaced with 
either 142.5 µL fresh normal DMEM medium or 142.5 µL inhibitory DMEM medium.  
The cells were incubated for 30 min, then treated with 7.5 µL of 100 µM compound 3.  
The cells were then incubated for 1 h, followed by confocal imaging as above.  Samples 
in inhibitory medium were then treated by removal of the medium, washing and removal 
of 200 µL of normal medium, replacement with 142.5 µL of normal medium and addition 
of 7.5 µL of 100 µM compound 3.  These samples were incubated for 1 h and then 
imaged once more. 
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DNase I Footprinting Titration Experiments 
A 3'-[32P]-labeled restriction fragment from the plasmid pDEH9 was generated in 
accordance with standard protocols and isolated by nondenaturing gel electrophoresis.19,20 
Table 4.1  Mass spectra for compounds 1-22. 
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Chapter 4B 
Influence of Structural Variation on Nuclear Localization of DNA-
Binding Polyamide-Fluorophore Conjugates 
 
Abstract 
 A pivotal step forward in chemical approaches to controlling gene expression is 
the development of sequence-specific DNA-binding molecules that can enter live cells 
and traffic to nuclei unaided.  DNA-binding polyamides are a class of programmable, 
sequence-specific small molecules that have been shown to influence a wide variety of 
protein-DNA interactions.  We have synthesized over 100 polyamide-fluorophore 
conjugates and assayed their nuclear uptake profiles in thirteen mammalian cell lines.  
The compiled dataset, comprising 1300 entries, establishes a benchmark for the nuclear 
localization of polyamide-dye conjugates.   
Compounds in this series were chosen to provide systematic variation in several 
structural variables, including dye composition and placement, molecular weight, charge, 
ordering of the aromatic and aliphatic amino-acid building blocks, and overall shape.  
Nuclear uptake does not appear to be correlated with polyamide molecular weight or with 
the number of imidazole residues, although the positions of imidazole residues affect 
nuclear access properties significantly.  Generally negative determinants for nuclear 
access include the presence of a β-Ala-tail residue and the lack of a cationic alkyl amine 
moiety, whereas the presence of an acetylated 2,4-diaminobutyric acid-turn is a positive 
factor for nuclear localization.  We discuss implications of this data on the design of 
polyamide-dye conjugates for use in biological systems. 
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Introduction 
Cell-permeable small molecules that preferentially bind to predetermined DNA 
sequences inside living cells would be useful tools in molecular biology, and perhaps 
human medicine.  Minor groove-binding polyamides containing the aromatic amino acids 
N-methylpyrrole (Py), N-methylimidazole (Im), N-methyl-3-hydroxypyrrole (Hp), and 
other related aromatic heterocycles bind DNA with affinities and specificities comparable 
to naturally occurring DNA-binding proteins.1-4 DNA recognition by polyamides is 
described by a code of side-by-side amino acid pairings that are oriented N→C with 
respect to the 5'→3'-direction of the DNA helix in the minor groove: Im/Py is specific for 
G•C, Hp/Py is specific for T•A, and Py/Py binds both A•T and T•A.1 
 Polyamides have been shown to influence a wide variety of protein-DNA 
interactions in solution,5-15 yet similar experiments in cell culture have proven to be 
dependent on cell-type.16-18  Studies with fluorescent Bodipy-labeled polyamides indicate 
that these conjugates are excluded from the nuclei of most cells, with the notable 
exceptions of lymphoid and myeloid cell types.19,20  One report suggested that the 
fluorophore itself may play a role in cellular uptake: an eight-ring polyamide-fluorescein 
conjugate was shown to accumulate in the nuclei of HCT-116 colon cancer cells.21  
Expanding upon this lead, we recently described a set of polyamide-fluorescein 
conjugates that localized to the nuclei of thirteen live mammalian cell lines.22  Relatively 
small structural alterations, such as differences in Py/Im sequence, caused dramatic 
changes in nuclear localization.  The current study seeks to elucidate more fully the 
structural requirements for nuclear localization of polyamide-fluorophore conjugates.  
This is a minimum first step in exploring the use of these DNA-binding ligands for gene 
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modulation in cell culture experiments. 
 
Results  
We have synthesized 100 polyamide-fluorophore conjugates, whose chemical 
structures are shown along with schematic ball-and-stick representations (e.g., Figure 
4.6).  We examined the nuclear localization properties of these compounds in thirteen 
mammalian cell lines, representing eleven human cancers, one human transformed 
kidney cell line, and one murine leukemia cell line.  Cells were allowed to incubate with 
polyamide-fluorophore conjugate in the surrounding medium (2 or 5 µM, as indicated, 
10-14 h) and the extent of nuclear uptake was analyzed by confocal microscopy.   
Polyamide-dye conjugates display a range of uptake efficiencies, varying from strong 
nuclear concentration, producing brightly stained nuclei with little or no signal in the 
medium or cytoplasm, to an absence of nuclear accumulation, in which case the 
molecules may be trapped in vesicles or excluded from cells entirely.  Within a single 
sample, staining is usually remarkably homogenous, displaying minimal cell-to-cell 
variation.   
The extent of nuclear localization for each sample was assigned one of four 
qualitative ratings, and these data are organized into tables showing the ball-and-stick 
structure of each compound and the level of uptake in each cell line (e.g.  Figure 4.7).  A 
thin vertical line separates data collected in adherent cell lines (left, MCF-7 through 293) 
from data collected in suspended cell lines (right, Jurkat through NB4).  Within these two 
sets, more permissive cell lines – those that generally display stronger nuclear staining 
with polyamide conjugates – are towards the left.  Thus, MCF-7 and Jurkat are the most 
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permissive cell types of the adherent and suspended cells, respectively.  Shaded 
groupings of compounds indicate structurally related conjugates, as discussed in the text.   
 
Dye composition 
We synthesized conjugates 1-20 to investigate the effect of the fluorophore 
moiety on nuclear localization (Figure 4.6).  Figure 4.7 shows the uptake profiles of these 
compounds.  Polyamides 1-6 are conjugated to fluorescein derivatives, and all show 
strong nuclear staining in the cell lines tested.  There appears to be flexibility in the 
specific type of chemical linkage, as thiourea (1, resulting from FITC conjugation) and 
amide (2-6) linkers are effective, including the extended thioether amide-linkage of 
Oregon Green® (OG) 514 in compound 5.  Fluorination of the aromatic rings is well 
tolerated (3-5), and replacing the carboxylic acid with a sulfonic acid (as in OG 500 
conjugate 4) appears to be somewhat beneficial in several cells lines (compare 
compounds 3 and 4).  The greater photostability of the fluorinated OG derivatives, as 
compared to fluorescein, may be advantageous for fluorescence imaging applications.28,29  
The JOE fluorophore, a fluorescein derivative with chloro and methoxy substituents, has 
red-shifted absorption and emission spectra compared to fluorescein, such that their 
spectra can be distinguished.  JOE conjugate 6 shows moderate to strong uptake in all cell 
lines, providing a second color for multicolor fluorescence applications.   
 Compounds 7-11, conjugated to rhodamine derivatives, display poorer nuclear 
localization profiles than analogous fluorescein conjugates.  The sulfonated rhodamine-
dye Alexa 488 is a highly photostable alternative to fluorescein; however, conjugate 7 
was completely excluded from the nuclei of all cells tested.  Rhodamine green derivative 
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8, lacking sulfonates, showed slightly stronger nuclear localization, particularly in 
adherent cell lines.  The additional alkyl groups in tetramethyl rhodamine (TMR) 
conjugate 9 impart enhanced uptake properties in most cell lines, compared to 8.  
Depending upon the cell type (as well as the ring sequence and composition of the 
polyamide, vide infra), polyamide-TMR conjugates may be useful because of the 
photostable, red/orange fluorescence of the TMR dye.  Compound 10 is conjugated to the 
related ROX fluorophore, and conjugate 11 incorporates a Texas Red fluorophore with a 
hexanoic acid spacer, a dye/linker combination that has been used to label polyamides for 
telomere staining experiments.30  Both polyamides, 10 and 11, are consistently excluded  
Figure 4.6  Dye composition.   Chemical and ball-and-stick structures of compounds 
1-20, testing the effect of differing dye composition on cellular uptake. 
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Figure 4.7  Dye composition: uptake profile of polyamides 1-20 in thirteen cell lines. 
Alternating highlighting indicates groups of chemically similar polyamides, as 
described in the text.  Data for adherent and suspended cells are towards the left and 
right, respectively, separated by a light gray vertical line.  Lighter shades of blue 
represent stronger nuclear localization.  + +, Nuclear staining exceeds that of the 
medium; +, nuclear staining less than or equal to that of the medium, but still 
prominent; –, very little nuclear staining, with the most fluorescence seen in the 
cytoplasm and/or medium; – –, no nuclear staining.  Except where noted, polyamide 
concentration was 2 µM.  aPolyamide described previously,22 assayed at 5 µM. 
bAssayed at 5 µM. 
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from live cells.   
 In compounds 12-14, a seven-carbon alkyl chain links the dye—FITC, TMR, and 
Bodipy FL (BoFL), respectively—to the polyamide.  For comparison, BoFL derivative 
15, incorporating the standard cationic triamine linker, is also included.  As described 
previously, the BoFL conjugate in this motif displays only minimal evidence of nuclear 
access in live cells.22  For each alkyl-linked conjugate, the loss of the tertiary amine in the 
linker worsened the uptake profile (compare 1 and 12, 9 and 13, and 15 and 14).  It was 
shown previously that alkyl-linked conjugate 12 performed much more poorly than 
triamine-linked conjugate 1, and that addition of an amino group at the turn residue, using 
the chiral H2Nγ-turn, restored most of the uptake properties (see compound 78, below).22  
In contrast, adding amino groups to the dye, as in alkyl-linked TMR conjugate 13, 
abolishes nuclear access. 
 Acetylating fluorescein produces a non-fluorescent, uncharged moiety; cleavage 
of the acetates by esterases subsequently unmasks the fluorophore.  Polyamide 16, as 
described previously,22 demonstrates that the AcHNγ-turn does not impede uptake, and the 
analogous diacetyl-FITC conjugate 17 stains nuclei with similar effectiveness.  It should 
be noted that no special effort was taken to remove esterases from the growth medium, 
such that some amount of 16 is likely to be in solution when cells are treated with 17.  
Polyamides 18-20 have the same number of Im and Py residues as compounds 1-17 but 
in a different sequence.  With the exception of the less permissive suspended cells MEL 
and NB4, FITC conjugate 18 (an isomer of 16) and OG 514 conjugate 19 display modest 
to strong nuclear staining.  In contrast, TMR conjugate 20 is a very poor nuclear stain.  
Comparing analogous compounds, conjugates 18 and 19 display only slightly poorer 
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uptake profiles than those of conjugates 1 and 5, respectively, whereas TMR conjugate 
20 is a much worse nuclear stain than polyamide 9.  Such comparisons indicate that 
modifications such as ring sequence and fluorophore structure interact to affect nuclear 
uptake in ways that are not yet predictable.   
 
Second-Generation Rings 
We have recently described several second-generation aromatic ring systems that 
improve the DNA-binding properties of polyamides.3,4  When paired against Py, a 
chlorothiophene (Ct) residue at the N-terminal cap position targets a T•A base pair.4  The 
hydroxybenzimidazole (Hz) moiety, incorporated as part of a dimeric subunit, appears to 
be a chemically stable replacement for the Hp residue,3 and a CtHz-cap dimer has 
recently been found to target the sequence 5’-TT-3’ (R.M.  Doss, M.A.  Marques, S.  
Foister, and P.B.  Dervan, unpublished results).  Figure 4.8 shows the chemical structures 
of polyamide-fluorophore conjugates incorporating second-generation rings, and Figure 
4.9 displays their uptake properties. 
Ct-cap compounds 21-24 have the same ring sequence but different dyes.  
Polyamides 21-23, conjugated to fluorescein derivatives, display strong nuclear 
localization, whereas TMR conjugate 24 displays a moderate uptake profile that is 
generally similar to 9 and better than 20.  Conjugates 25-28 demonstrate the effects of 
different ring sequences on nuclear uptake of thiophene-cap conjugates.  Whereas 25 
displays good to excellent nuclear staining, its isomer 26 is excluded from all cells tested.  
Other conjugates with three contiguous Im residues – methylthiophene-cap polyamide 
27, and ten-ring hairpin 28 – also display very poor uptake properties.  The only  
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Figure 4.8  Second-generation rings.   Chemical and ball-and-stick structures of 
compounds 21-36, testing the effect of new aromatic rings on cellular uptake. 
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exception is relatively modest and heterogeneous uptake of 27 in MEG-01 cells.  
Contrasting these data with the generally good to excellent nuclear staining displayed by 
18 and 19, which also contain three contiguous imidazole residues, reemphasizes the 
complexity of the interactions between polyamide-fluorophore conjugates and cells. 
 Polyamides 29-31, each with a chiral H2Nγ-turn, differ only in cap-residue 
Figure 4.9  Second-generation rings: uptake profile of polyamides 21-36.   Symbols 
are defined in Figure 4.7.   Except where noted, polyamide concentration was 2 µM. 
aAssayed at 5 µM.  bHighly heterogeneous uptake profile.  Some cells display clear 
nuclear localization, while others show none.  The value shown is an approximate 
average. 
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structure.  Compounds 29 and 31, with Im and Ct caps, respectively, are excellent nuclear 
stains, whereas Py-cap polyamide 30 is significantly less effective.  It is remarkable that 
an Im→Py conversion (29 to 30), formally an N→C-H shift, reduces nuclear uptake, but 
the more dramatic Im→Ct conversion affects uptake very little.   
 Based on the ring sequence of 21-24, compounds 32-36 incorporate variants of 
the benzimidazole ring system.  Although polyamides incorporating the Hz unit display 
favorable DNA-binding properties, FITC conjugate 32 stains the nuclei of only a few cell 
lines, and OG 514 conjugate 33 stains only MCF-7 and LNCaP cells.  Modifications to 
the hydroxyl group, including acetylation (34) and conversion to a methoxy group (35), 
did not improve the uptake profile.  Complete removal of the hydroxyl group (36) allows 
nuclear localization in many cell lines, though the uptake profile does not correlate with 
the general permissiveness of the cell types.  Furthermore, removing the hydroxyl 
eliminates the ability to distinguish between A•T and T•A base pairs at that position.3  
 
Extended Hairpin Motif 
Figure 4.10 shows the chemical structures of polyamide-dye conjugates 37-46 
with C-terminal unpaired rings, and Figure 4.11 shows their uptake profiles.  The 
molecules are grouped into pairs that differ with respect to the conjugated dye.  Although 
the DNA-binding properties of the extended hairpin motif have not been studied as 
extensively as those of fully ring-paired hairpin polyamides,31,32 extended hairpin 
polyamides have been shown to interfere with NF-κB—DNA interactions13 and to label 
specific heterochromatic regions of human chromosomes.29  Furthermore, tandem 
polyamides with extended hairpin subunits have been used to stain telomeres30 and to 
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displace a viral transcription factor from DNA.33  Overall, conjugates 37-46 display good 
to excellent nuclear localization properties.   
 Seven-ring polyamides 37 and 38, conjugated to FITC and OG 514, respectively, 
are moderately effective nuclear stains.  The larger nine-ring FITC conjugate 39 displays 
a significantly improved uptake profile, whereas OG 514 conjugate 40 is similar to the 
seven-ring hairpins.  Polyamides 41 and 42 have a similar nine-ring core, but with a 
single unpaired Py residue and a chiral AcHNγ-turn.  Both the FITC and FAM conjugate 
(41 and 42, respectively) are excellent nuclear stains.  From these compounds, one 
Figure 4.10  Extended hairpins.  Chemical and ball-and-stick structures of compounds 
37-46, testing the effect of extensions to the hairpin motif on cellular uptake. 
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Py→Im substitution gives 43 and 44, respectively.  In this case, FAM conjugate 44 
performs better than FITC conjugate 43.  Based on a motif that was used in studies with 
NF-κB,13 compounds 45 and 46 have two unpaired Py residues.  Again, the FAM 
conjugate displays the better uptake profile, strongly staining the nuclei of eight of the 
thirteen cell lines.   
 
Larger Polyamides 
Somewhat larger than the extended hairpin polyamides 37-46 are fully ring-paired 
hairpins 47-54 and 56-62.  Figure 4.12 shows the structures of dye conjugates 47–62, and 
Figure 4.13 displays their uptake profiles.  Many of these compounds incorporate the 
flexible β-Ala residue, which is often substituted for Py to allow polyamides to adapt to 
sequence-dependent DNA microstructure and flexibility.34,35  In general, conjugates of  
Figure 4.11  Extended hairpins: uptake profile of polyamides 37-46. Symbols are 
defined in Figure 4.7. 
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Figure 4.12  Larger polyamides.  Chemical and ball-and-stick structures of 
compounds 47-62, testing the effect of molecular size on cellular uptake. 
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this motif display poor to moderate nuclear staining, although there are scattered 
exceptional cases.   
 Conjugate 47, described previously, displayed a particularly poor uptake profile.  
From 47, an Im→Py substitution produces 48, which displays some nuclear staining in 
eight cell lines.  Chiral AcHNγ-turn analogs of 48, conjugates 49 and 50, display improved 
uptake properties, accessing the nuclei of most of the cell types, and showing excellent 
staining in some of the more permissive adherent cells.  Polyamides 51 and 52 (related to 
Figure 4.13  Larger polyamides: uptake profile of polyamides 47-62. Symbols are 
defined in Figure 4.7.  Except where noted, polyamide concentration was 2 µM. 
aPolyamide described previously,22 assayed at 5 µM. 
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49 and 50, respectively, by Py→β-Ala substitutions of the central residues), are less 
efficient nuclear stains, with FAM conjugate 52 performing significantly more poorly.  
Compounds 53 and 54 result from an additional Py→Im substitution.  FITC conjugate 53 
accesses the nuclei of the more permissive adherent cells, whereas FAM conjugate 54 
displays a scattered uptake profile.   
 Polyamides 55-59 are designed to target essentially the same 6-bp DNA sequence.  
Eight-ring hairpin 55, included as a reference, is excluded from all cell nuclei, whereas 
the larger polyamides access nuclei somewhat more successfully.  In this set, internal β-
Ala substitution and FAM-conjugation are both positive determinants for nuclear uptake; 
accordingly, conjugate 59 is the most effective nuclear stain.  Polyamide 60 is related to 
58 by a Py→Im substitution, and 60 displays a much poorer uptake profile.  Inverting the 
strands of 60 produces 61 – the result of a formal 180° rotation of the ring core – which is 
excluded from the nuclei of all cells tested.  Conjugate 62 is based on a motif that has 
been employed in a variety of studies;18,20,36 however this FITC conjugate is excluded 
from cell nuclei.   
 
C-terminal β-Ala Residues 
In a previous study, we noted that adding β-Ala residue to the C-terminal (“tail”) 
position of a polyamide-dye conjugate could have dramatic effects on nuclear 
localization.22  We therefore synthesized the molecules shown in Figure 4.14 to 
investigate the effects of β-Ala-tail residues.  To allow for the possibility that the added 
β-Ala would enhance uptake, precursor ring systems were chosen to have a range of 
uptake efficiencies (Figure 4.15).  The polyamides are grouped by their core ring  
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Figure 4.14  β-Alanine tails.  Chemical and ball-and-stick structures of compounds 
63-77, testing the effect of molecular size on cellular uptake. 
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sequence.  In almost every case, adding a β-Ala-tail residue reduces nuclear uptake 
efficiency.  Indeed, even in cases in which both samples have the same qualitative rating, 
the conjugate with a β-Ala-tail shows slightly less intense nuclear staining. 
 Conjugate 63 is an excellent nuclear stain, and addition of a β-Ala-tail residue 
(compound 64) affects uptake only minimally.  In contrast, polyamide 65 displays a 
moderate to good uptake profile, and its β-Ala-tail analog 66 shows very poor nuclear 
staining.  Although FITC conjugate 68 (an isomer of polyamide 1) accesses nuclei 
slightly more effectively than FAM conjugate 67, it is nonetheless a rather weak stain, 
Figure 4.15  β-Alanine tail residues: uptake profile of polyamides 63-77. Symbols are 
defined in Figure 4.7.  Except where noted, polyamide concentration was 2 µM. 
aPolyamide described previously,22 assayed at 5 µM. bAssayed at 5 µM. 
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and addition of a β-Ala-tail residue (conjugate 69) completely inhibits nuclear access.  
Conjugate 70, described previously,22 accesses the nuclei of only two cell lines, and 
addition of a β-Ala-tail residue (compound 71) does not change the uptake profile 
significantly.  Polyamides 72-77 have the same ring sequence, but vary with respect to 
dye structure, turn substitution, and the presence of a β-Ala-tail residue.  Of this series, 
only FITC conjugate 72 (with an AcHNγ-turn and lacking a β-Ala-tail) displays an 
excellent uptake profile.  Polyamide 72 is isomeric with compounds 58 and 62, and of 
these three conjugates, 72 displays by far the most efficient nuclear staining.  
Interestingly, although the overall uptake profile of FAM conjugate 77 is relatively poor, 
this β-Ala-tail polyamide is one of three compounds in Figure 4.15 that can access the 
nuclei of MEL cells.   
 
Turn-linked conjugates  
To investigate other dye-attachment points, conjugates were synthesized linked to 
the chiral turn element (80-88, Figure 4.16).  For comparison, this set includes tail-
conjugated polyamides 78, 79, and 89.  Figure 4.17 presents the uptake profiles of 78-89.   
Polyamides 78 and 79 are conjugated to FITC through seven- and six-methylene spacers, 
respectively.  Neither compound stains nuclei as effectively as the analogous conjugate 1, 
although 79 is quite close.  Compared to 78, polyamide 80 exchanges the positions of the 
cationic amine group and the dye linker.  These turn-linked FITC conjugates are excellent 
nuclear stains, and the presence of an additional amine (in 81) or a β-Ala-tail residue (in 
82) does not impede nuclear uptake.  The sole exception is compound 81 in NB4, a cell 
line which was previously observed to exclude polyamide-dye conjugates with added  
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positive charges.22  
  Hairpin polyamides 83-88, linked to BoFL through the turn, differ with respect to 
Py/Im composition, and are analogous to the tail-linked FITC conjugates 1, 89, 65, 68, 
70, and 48, respectively.  Although each eight-ring BoFL turn-conjugate is a less 
effective stain than the corresponding FITC tail-conjugate, relative uptake efficiency 
within each motif appears to be influenced primarily by ring composition.  Indeed, 
ranked by average effectiveness, 83 ≈ 84 > 85 > 86 ≈ 87, and correspondingly, 1 ≈ 89 > 
65 > 68 ≈ 70.  Ten-ring BoFL-turn conjugate performs similarly to its FITC-tail analog 
48, although the AcHNγ-turn derivative 49 is a significantly better nuclear stain than either 
Figure 4.16  H2Nγ-turn-linked conjugates.  Chemical and ball-and-stick structures for 
polyamides 78-89, testing the effect of removing the dye moiety to the H2Nγ-turn. 
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conjugate.  The favorable uptake properties of some of these BoFL-turn conjugates– 
particularly in more permissive cell lines–is somewhat surprising in comparison to the 
poor nuclear localization profile of tail-linked BoFL conjugate 15 (Figure 4.7). 
 
Shapes 
Beyond hairpin polyamides derivatized at the turn, a variety of unique polyamide 
shapes have been described, including N-methyl substituted hairpins,13-15,37,38 cycles,39,40 
U-pins,26 H-pins,27,41 and tandem hairpins.30,33,42  Figure 4.18 shows the chemical 
structures of dye conjugates of various shapes, and Figure 4.19 presents their uptake 
profiles.   
Figure 4.17  H2Nγ-Turn-linked conjugates: uptake profile of polyamides 78-89. 
Symbols are defined in Figure 4.7.  Except where noted, polyamide concentration was 
2 µM. aPolyamide described previously,22 assayed at 5 µM. bAssayed at 5 µM. 
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 FITC conjugate 90, linked through an N-propylamine Im-cap residue, is a poor 
nuclear stain, as described previously.22  After evaluating other compounds, and noting 
that effective compounds incorporated a cationic amine group, we synthesized compound 
91 (an isomer of conjugate 1), which demonstrated good to excellent uptake properties.  
Correspondingly, cyclic polyamide 92 displayed a very poor uptake profile.  In contrast, 
U-pin polyamide 93 is a moderately good nuclear stain, especially in adherent cells.   
 Uptake data for H-pin polyamides indicates that a motif cannot be evaluated by a 
handful of molecules alone.  Of the six-ring H-pins, 95 (the peracetylated derivative of 
Figure 4.18  Shape variation.  Chemical and ball-and-stick structures of compounds 
90-100, testing the effect of molecular shape on cellular uptake. 
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94) showed highly heterogeneous staining in a small number of cell lines.  Within a 
single microscope frame, some cells were brightly stained, while others were completely 
dark – where indicated, the data in Figure 4.17 represent a rough average across the cells.  
Ten-ring H-pins 96 and 97 were excluded from all cells tested, whereas 98 (the ten-ring 
analog of 95) showed good to excellent staining in all but the least permissive cell lines.  
In line with trends observed earlier, adding C-terminal β-Ala residues (compound 99) 
diminishes the uptake efficiency.   
 Tandem hairpins can target longer sequences of DNA than standard hairpin 
polyamides, so the complete exclusion of FITC conjugate 100 from cells is somewhat 
disappointing.  However, it is possible that another tandem, containing a different Py/Im 
sequence, dye, or other variation might access the nuclei of some cell types. 
Figure 4.19  Shape variations: uptake profile of polyamides 90-100. Symbols are 
defined in Figure 4.7.  Except where noted, polyamide concentration was 2 µM. 
aPolyamide described previously,22 assayed at 5 µM. bAssayed at 5 µM. cHighly 
heterogeneous uptake profile. Some cells display clear nuclear localization, while 
others show none. The value shown is an approximate average. 
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Short Peptides 
 The successful staining of the nuclei of mammalian cells with polyamides labeled 
with fluorescein and other similar dyes permits many transcription inhibition experiments 
to be attempted with confidence that a negative result is not due to exclusion of active 
compound from genomic DNA.  However, there are many applications requiring 
polyamides to be conjugated to peptide and small molecule moieties.  The uptake 
characteristics of these compounds must be good in order to proceed with in vivo 
experiments.  As a first-pass attempt, a small set of polyamide-peptide-fluorophore 
conjugates have been prepared (Figure 4.20) and their uptake characteristics measured.  
The synthetic scheme for 101-105 is shown in Figure 4.21.  In general, the uptake of 
these conjugates is poor, with the compounds being excluded from or sequestered in the 
cytopoasm of all cell lines studied (Figure 4.22).  Further work will be necessary to 
determine whether this is a general characteristic of polyamide-peptide conjugates, or if 
some privileged structures might permit good nuclear uptake. 
 
Discussion 
From this sea of data, certain trends can be discerned.  There does not appear to 
be any clear correlation between molecular weight and nuclear uptake.  Indeed, additional 
residues can improve uptake (compare, e.g., 37 and 39, or 55 and 59), or impede it 
(compare 1 and 47, or 48 and 63).  Similarly, a Py→β-Ala exchange, which reduces 
molecular weight, may intensify or diminish nuclear staining (Figure 4.15).  The 
acetylated AcHNγ-turn, which adds molecular weight compared to an unsubstituted γ-turn, 
is one of the few consistently positive factors for nuclear localization (for example, 
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compare 1 and 16, 48 and 49, or 72 and 73).  Generally negative determinants for nuclear 
access include the presence of a β-Ala-tail residue and the lack of a cationic alkyl amine 
moiety.   
Although there is no general correlation between the number of Im residues and 
uptake efficiency, the positions of Im residues clearly affect nuclear access.  For example, 
Figure 4.20  Small peptides.  Chemical and ball-and-stick structures of compounds 
101-105, testing the effect on cellular uptake of the addition of small peptide moieties 
to polyamide-fluorophore conjugates. 
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structural isomers often display very different uptake profiles (compare eight-ring 
polyamides 1, 65, and 68, or larger conjugates 58, 62, and 72).  Furthermore, a Py→Im 
exchange is nearly always a negative determinant for nuclear access (except at the cap 
position, compare 29 and 30), and the impact is highly dependent on the position of the 
residue and the overall polyamide motif.  For example, in eight-ring polyamide-dye 
conjugates the effect of a single Py→Im exchange may be very small (89 versus 1), 
Figure 4.21  Synthesis of small peptide conjugates.  (i) 3,3’-diamino-N-methyl-
dipropylamine, 6 hrs at 37ºC.  (ii) R2Tyr, DCC, HOBt, DIEA, DMF.  (iii) 20% (v/v) 
piperidine/DMF.  (iv) (D) Asp-Ph2ipr, DCC, HOBt, DIEA, DMF.  (v) 20% (v/v) 
piperidine/DMF.  (vi) Bodipy-FL, DCC, HOBt, DIEA, DMF.  (vii) 20% (v/v) 
TFA/CH2Cl2. (viii) Peptide, DCC, HOBt, DIEA, DMF.  (ix) 20% (v/v) 
piperidine/DMF.  (x) FITC, DIEA, DMF.  (xi) 20% (v/v) TFA/CH2Cl2. 
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modest (63 versus 65), or severe (1 versus 70).   
 The role of charge in nuclear uptake is particularly intriguing, though uptake does 
not appear to correlate with net charge.  At neutral pH, fluorescein conjugates that 
efficiently access cell nuclei have a net charge of -1 (the majority of conjugates, 
exemplified by 1) or a net charge of 0 (such as 29, 31, and 81).  However, polyamide-
fluorescein conjugates have been observed to accumulate in acidic vesicles (reference 21 
and data not shown), in which the pH is between ~4.5 and 6.43  Because the pKa’s of the 
phenolic protons of fluorescein and OG derivatives are ~6.4 and ~4.7, respectively,44 the 
phenol moiety will be fully or partially protonated in acidic vesicles.  Thus, in such 
subcellular structures, polyamide-fluorescein conjugates such as 1 would have a net 
charge of 0, whereas conjugates such as 29 would have a net charge of +1.   
 It may be that the ability to change protonation state enhances the nuclear 
localization properties of fluorescein conjugates relative to rhodamine and bodipy 
derivatives, which are pH insensitive.  TMR and BoFL conjugates having a net charge of 
0 (compounds 13 and 14) or +1 (compounds 8-11, 15 and 83-88) all perform significantly 
more poorly than analogous fluorescein conjugates.  It is remarkable that moving the 
Figure 4.22  Small peptides: uptake profile of polyamides 101-105. Symbols are 
defined in Figure 4.7.  Polyamide concentration was 2 µM. 
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positive charge from the linker to the dye is not tolerated whatsoever (compare triamine-
linked FAM conjugate 2 and alkyl-linked TMR conjugate 13, Figure 4.7), whereas 
relatively well-tolerated alterations include moving the positive charge to the turn 
(compare FITC conjugates 1 and 78) and moving the dye to the cap residue, effectively 
increasing the distance between the anionic and cationic moieties (compare FITC 
conjugates 1 and 91).   
 Conjugation to fluorescein appears to facilitate uptake for this class of molecules, 
though it is not essential: TMR conjugate 9 is an excellent nuclear stain in several cell 
lines, and turn-linked BoFL conjugates 83, 84, and 88 display improved uptake profiles 
compared to the tail-linked BoFL derivative 15.  Indeed, polyamides without any 
attached fluorophore have been shown to induce biological effects in living cells, albeit in 
a limited number of cell types.  Whereas 62 was excluded from cells, an analog of 62 
without a dye-label altered gene expression in live lymphoid cells, and a non-dye-labeled 
chorambucil derivative of 62 was shown to alkylate genomic DNA in live cells.20  This 
example highlights the distinct properties of dye-conjugated versus unlabeled 
polyamides.  One cannot be considered as a “proxy” for the other, regarding cellular 
localization characteristics or other properties.  Fluorescent polyamide conjugates are 
unique because their ability to access nuclei can be assessed directly, and it is our intent 
to use such labeled polyamides in biological studies involving live cell systems.   
 Although the uptake data presented here do not allow for prediction of nuclear 
uptake properties a priori, rough design guidelines are apparent.  Synthesizing and 
analyzing a small, focused library of polyamide-fluorophore conjugates appears to be the 
optimal approach.  Key points of variation are ring sequence (if possible on a given 
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target), dye composition (FITC, FAM, OG 514, etc.) and position of conjugation, turn 
substitution (γ-turn or AcHNγ-turn), and β-Ala incorporation.  Examples of such focused 
libraries are compounds 55-59, 72-77, and 96-99.   
 For use in live-cell studies, polyamides must now be optimized along three axes: 
DNA-binding affinity and specificity, in vitro biochemical activity, and nuclear 
localization.  For the first and second axes, assays such as DNase footprinting, gel shift, 
and in vitro transcription are well established, and studies based on these techniques 
continue to expand the scope and utility of DNA-binding polyamides.3,12,15,45  The current 
study employs an assay based on confocal microscopy to establish a benchmark dataset, 
comprising 1300 entries, for nuclear localization of DNA-binding polyamide-dye 
conjugates.  Live-cell studies with these compounds are currently in progress, as are 
efforts to elucidate the energy-dependent mechanism of uptake.22  Understanding nuclear 
accessibility in a wide variety of living cells is a minimum first step toward chemical 
regulation of gene expression with this class of molecules. 
 
Experimental 
Chemicals 
Polyamides were synthesized by solid phase methods on Boc-β-ala-PAM resin 
(Peptides International, Louisville, KY)23 or on Kaiser oxime resin (Nova Biochem, 
Laufelfingen, Switzerland).24 Synthetic protocols for second-generation building blocks 
(incorporated into polyamides shown in Figure 4.8 and polyamides 90 and 91, Figure 
4.17) are essentially as described.2-4,25  The polyamide precursor to compound 92 was 
synthesized as follows: 
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Cbz- γ -ImImPyPy- (R) FmocHNγ -ImPyPyPy-Oxime was prepared using the Kaiser 
oxime resin as previously described.24  The Fmoc-protecting group was cleaved by 20% 
(v/v) piperidine/DMF cleavage (4 x 3 min) and replaced by a t-Boc group upon treatment 
with Boc2O, DIEA, and DMF.  The polyamide was cleaved from resin by first swelling 
dried resin in dioxane (500 mg resin, ~1 mL dioxane) for 1 hr, and then adding a solution 
of 3:1 dioxane:NaOH (1M aqueous) and allowing the resin to cleave at 37ºC for 36 hrs.  
Filtration of the resin and a second treatment with fresh cleavage solution yields further 
crude product, all of which was purified by C18 reverse-phase HPLC and lyophilized to 
provide polyamide as a white powder (~10% yield). 
Cbz- γ -ImImPyPy- (R) BocHNγ -ImPyPyPy-COOH (8 µmol) was dissolved in 1:1 
absolute EtOH:CH2Cl2 (5 mL), to which was added first Pd(OAc)2 (0.2 g, 950 µmol), 
then ammonium formate (0.3 g, 4.7 mmol).  The solution was stirred at room temperature 
under Ar for 20 min.  The solution was centrifuged to remove precipitated PdO, purified 
by C18 reverse-phase HPLC, and lyophilized to provide polyamide as a white powder 
(~25% yield). 
H2N- γ -ImImPyPy- (R) BocHNγ -ImPyPyPy-COOH (2.2 µmol) was dissolved in 
DMF (4 mL).  K2CO3 (0.11 g, 0.8 mmol) that had been dried at 130ºC was added and the 
mixture was stirred for 1 hr.  DPPA (14.5 µL, 67 µmol) was added and the mixture was 
stirred for 4 hrs.  The solution was concentrated to a brown film, which was treated with 
80% (v/v) TFA/CH2Cl2 for 45 min, concentrated, purified by C18 reverse-phase HPLC, 
and lyophilized to provide polyamide as a white powder (~25% yield).  Polyamide cyclo-
(γ -ImImPyPy- (R)H2Nγ -ImPyPyPy-) was treated with fluorescein amide-C6 linker 
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succinimidyl ester as with other dye additions, purified, and lyophilized to provide 92 as 
an orange powder (~50% yield). 
U-pin 93 and H-pins 94-99 were synthesized according to methods described in 
references (26) and (27), respectively. After cleavage with the appropriate amine and 
reverse-phase HPLC purification, polyamides were dissolved in DMF and treated with 
diisopropylethylamine (DIEA) (20 eq) followed by the fluorophore in the form of an 
isothiocyanate, an N-hydroxysuccinimidyl ester, or a free acid activated in situ with 
HBTU. Fluorophores were delivered as solutions in DMF or DMSO. After reacting at rt 
for ~3 h, the resulting dye conjugates were purified by HPLC.  
Peracetylated polyamides 17, 34, 95, 98, and 99 were obtained by treating the 
precursor polyamides with acetic anhydride and DIEA in DMF for ~30 min. For 
compounds with a free (R)-2,4-diaminobutyric acid (H2Nγ-turn) moiety (29-31, 76, 78, 79, 
and 100), the protected FmocHNγ-turn amine was deprotected (20% piperidine-DMF) and 
reprotected as the Boc derivative (Boc2O, DIEA, DMF) immediately prior to cleavage of 
the polyamide from resin. After conjugation of the dye moiety, these compounds were 
treated with TFA and purified by HPLC.  
Compounds 101-105 were prepared as shown in Figure 4.21.  The peptides for 
104 and 105 were prepared on SASRIN resin (Bachem), cleaved with 1% (v/v) TFA in 
CH2Cl2, and purified on silica, retaining the side-chain protection on the aspartic acid and 
tryptophan residues.  The identity and purity of each compound was verified by analytical 
HPLC, UV-visible spectroscopy, and matrix-assisted laser desorption ionization/time-of-
flight mass spectrometry (MALDI-TOF). Table 4.2 lists the masses calculated and found 
for all conjugates.  All fluorescent dye reagents were from Molecular Probes. Chemicals 
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not otherwise specified were from Sigma-Aldrich. 
 
Cell Cultures  
The human cancer cell lines MCF-7, PC3, LNCaP, DLD-1, 786-O, Jurkat, CCRF-
CEM (CEM), MEG-01, and NB4 were cultured in a 5% CO2 atmosphere at 37°C in 
supplemented RPMI medium 1640. The human cancer cell line HeLa, the murine 
leukemia cell line MEL, and the transformed human kidney cell line 293 were grown as 
above in supplemented DMEM. The human cancer cell line SK-BR-3 was cultured as 
above in supplemented McCoy’s medium. All media were supplemented with 10% fetal 
bovine serum (Irvine Scientific) and 1% penicillin/streptomycin solution (Sigma). 
 
Confocal Microscopy  
Adherent cell lines (MCF-7, HeLa, PC3, LNCaP, SK-BR-3, DLD-1, 786-O, and 
293) were trypsinized for 5–10 min at 37°C, centrifuged for 5 min at 5°C at 900 g, and 
resuspended in fresh medium to a concentration of 1.25 x 106 cells per ml. Suspended 
cell lines (Jurkat, CEM, MEG-01, MEL, and NB4) were diluted in fresh medium to the 
same concentration. Incubations were performed by adding 150 µl of cells into culture 
dishes equipped with glass bottoms for direct imaging (MatTek, Ashland, MA). Adherent 
cells were grown in the glass-bottom culture dishes for 24 h. The medium was then 
removed and replaced with 147 µl (or 142.5 µl) of fresh medium. Then 3 µl (or 7.5 µl) of 
the 100 µM polyamide solution was added for final polyamide concentration of 2 µM (or 
5 µM), as noted in the data tables. Cells were incubated in a 5% CO2 atmosphere at 37°C 
for 10–14 h. Suspended cell line samples were prepared in a similar fashion, omitting 
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trypsinization. These samples were then incubated as above for 10–14 h. Imaging was 
performed with a x40 oil-immersion objective lens on a Zeiss LSM 5 Pascal inverted 
laser scanning microscope. The optical slice was set to 2.2 µm. Images were line-
averaged 2, 4, 8, or 16 times and were obtained at a 0.8 µs/pixel scanning rate. 
Polyamide-dye conjugate fluorescence and visible light images were obtained using 
standard filter sets appropriate for fluorescein, rhodamine, or Texas Red. 
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Table 4.2  Mass spectrometry data for compounds 1-105. 
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101 H                      1747.8       1749.6 
102 H            1999.6        1998.7 
103 H             1837.8        1838.6 
104 H                          2144.9        2149.3 
105 H                          2126.9        2127.6  
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Chapter 4C 
DNA-Binding Characteristics of Polyamide-Fluorophore Conjugates 
Abstract 
 The successful staining of the nuclei of mammalian cells with polyamides labeled 
with fluorescein and other similar dyes permits many transcription inhibition experiments 
to be attempted with confidence that a negative result is not due to exclusion of active 
compound from genomic DNA.  However, accompanying the need for good cellular 
uptake properties is the need for polyamides or polyamide conjugates to possess good 
DNA-binding properties.  The effect of fluorophore conjugation on the affinity and 
specificity of polyamides for DNA is an important question pertaining to the use of these 
compounds as transcriptional regulators. 
 Several polyamide-fluorophore conjugates have been synthesized and their DNA-
binding properties tested by DNase I footprinting titration experiments.  In general, 
fluorescein conjugation is most tolerated at the C-terminal tail, resulting in a 5- to 25-fold 
decrease in affinity while retaining specificity.  The effects of attachment off of the chiral 
turn residue and the N-terminal imidazole 4-amino group were also probed.  Fluorescein 
conjugation to either of these positions resulted in a ~100-fold decrease in binding 
affinity with reference to the tail conjugate.  Surprisingly, attachment of a Bodipy 
fluorophore from the turn residue results in a somewhat lesser 10-fold decrease in 
affinity, as compared to the tail-linked fluorescein conjugate. 
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Results 
 Compounds 1-6 were synthesized, linking the fluorescein moiety through the 
polyamide C-terminal tail (Figure 4.23).  These polyamides target several different DNA 
binding sites, and were all shown to stain the nuclei of several different cell lines.  
Polyamides 1-3 were footprinted on a plasmid derived from the γ-globin promoter 
(Figure 4.24). 
Figure 4.23  Chemical structures and ball-and-stick models of tail-linked polyamide-
FITC conjugates 1-6. 
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Figure 4.24  Footprinting of 1-3.  (a) γ-globin promoter PCR fragment used for 
footprinting reactions.  (b) Footprinting gels and isotherms for compounds 1-3. 
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 The affinities of compounds 1-3 are reduced with reference to polyamides lacking 
the fluorescein moiety.  The precise degree of this reduction is complicated by two 
factors.  First, it is unclear which are the best choices of parent polyamides against which 
to compare binding characteristics.  Second, for truly accurate comparisons to be made, 
both the polyamide and its conjugate must be footprinted in exactly the same sequence 
context, preferably on the same plasmid.  Though imperfect, it is possible to make useful 
comparisons between the footprinting data reported here and past data. 
Table 4.3 shows comparative data between compounds 1-3 and related 
polyamides 7-9.  There is a 4- to 25-fold decrease in binding affinity upon addition of the 
fluorescein moiety.  The large differences in affinity decrease between compounds is 
most likely due to the imperfect comparisons that may be drawn between 1-3 and 7-9, as 
well as the differing DNA contexts.  However, the general effect of FITC addition seems 
to be an approximately 10-fold reduction in affinity, with good specificity. 
Table 4.3  Comparison between the DNA-binding affinities of polyamides and 
polyamide-FITC conjugates. 
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Figure 4.25  Footprinting of 4-6.  (a) pTPB1 restriction fragment used for footprinting 
reactions.  (b) Footprinting gels and isotherms for compounds 4-6. 
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 The affinities of compounds 4 and 6 are similar in magnitude to those of 
compounds 1-3, while the affinity of 7-ring compound 5 is substantially lower, probably 
reflecting a parent polyamide with poor affinity (Figure 4.25).  Though their affinities are 
almost certainly reduced with reference to polyamides lacking the fluorescein moiety, 
there is no footprinting data available for likely parent polyamides.  As for compounds 
10-13, they all are related to compound 7, to varying degrees, and even more closely to 
compound 1, differing mainly in the placement of the fluorophore moiety (Figure 4.26).  
Only compound 10, which is structurally very similar to 1, possesses a low nanomolar 
binding affinity.  None of the other compounds have affinities as high as 1, though 
surprisingly the Bodipy compound 13 has a 10-fold higher affinity than either 11 or 12, 
which are both 100-fold lower than 1 (Figure 4.27).  It should be noted that while 
compounds 10 and 13 were footprinted on the plasmid pDEH9, 11 and 12 were 
footprinted on the γ-globin plasmid (Figure 4.24a). 
Figure 4.26  Chemical structures and ball-and-stick models of compounds 10-13. 
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Figure 4.27  Footprinting of 10-13.  (a) pDEH9 restriction fragment used for 
footprinting reactions.  (b) Footprinting gels and isotherms for compounds 10-13. 
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 An examination of the binding 
affinities of compounds 10-13 in 
comparison with those of 1 and 7 show that 
attachment of the fluorophore moiety from 
either the turn or the N-terminal imidazole 4-
amino- group causes a large reduction in 
binding affinity.  Attachment of FITC from 
the N-terminus results in 100- to 1000-fold 
reduction of affinity with reference to a parent 
polyamide.  A comparable affinity reduction is 
seen when FITC is attached from the chiral 
turn via a C7 aliphatic linker.  It turns out that 
this affinity can be improved by attaching 
Bodipy in this position, via a C5 aliphatic 
linker, for an overall 10- to 100-fold reduction 
in affinity with reference to polyamide.  
Attachment of these fluorophores from 
alternate positions seems to lead to a loss of 
sequence specificity in addition to the affinity drop.  In general, this bodes poorly for 
using polyamide-fluorophore conjugates connected through alternate strategies as 
reagents to regulate gene transcription in living systems, despite the ready nuclear 
localization of compounds 11-13. 
Table 4.4  Comparison of alternate motifs 
for polyamide-FITC conjugates. 
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Experimental 
Chemicals 
 All polyamide precursors to 1-6 and 10-13 were synthesized on either Boc-β-Ala-
PAM resin or Kaiser oxime resin, as previously described.1,2  Polyamides were labeled 
with fluorophores by treatment with fluorescein isothiocyanate (1.5 eq) and DIEA (>25 
eq) in DMF (100-200 µL). 
 
DNase I Footprinting Titrations 
5’ or 3’ 32P-labeled PCR fragments were generated from template plasmid p γ-
globin, pDEH9, or pTPB1 in accordance with standard protocols and isolated by 
nondenaturing gel electrophoresis.3  All DNase I footprinting reactions were carried out 
in a volume of 400 µL.  A polyamide stock solution or water (for reference lanes) was 
added to TKMC buffer, with final concentrations of 50 mM Tris-HCl, 50 mM KCl, 50 
mM MgCl2, and 25 mM CaCl2, pH 7.0, and 15 kcpm 5’-radiolabeled DNA.  The 
solutions were equilibrated for 12-18 h at 22°C.  Cleavage was initiated by the addition 
of 10 µL of a DNase I stock solution and was allowed to proceed for 7 min at 22°C.  The 
reactions were stopped by adding 50 µL of a solution containing 2.25 M NaCl, 150 mM 
EDTA, 0.6 mg/mL glycogen, and 30 µM base pair calf thymus DNA and then ethanol 
precipitated.   The cleavage products were resuspended in 100 mM Trisborate-
EDTA/80% formamide loading buffer, denatured at 85°C for 10 min, and immediately 
loaded onto an 8% denaturing polyacrylamide gel (5% cross-link, 7 M urea) at 2000 V 
for 2 h and 15 min.   The gels were dried under vacuum at 80 °C and quantitated using 
storage phosphor technology. 
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Chapter 5 
 
Inhibition of Transcription on the Androgen Response Element 
with Polyamides and Polyamide Conjugates 
 156
Abstract 
 Upon binding an androgen molecule, androgen receptor (AR) acts as a 
transcriptional activator on genes bearing one of the several androgen-response elements 
(ARE) in the 5’ upstream promoter region.  The prostate specific antigen (PSA) gene is 
among several genes regulated through an ARE.  The AR-ARE interaction is inhibited 
upon treatment with minor groove binding polyamides targeted to the ARE site.  
Inhibition of AR binding to the ARE is expected to decrease the transcription of PSA, 
which is shown in a transient transfection assay utilizing a luciferase gene under control 
of an ARE.  Attempts to extend these results to native gene transcription in live cells 
were unsuccessful.  Polyamide-fluorescein conjugates of the active polyamides were 
found to spontaneously enter the nuclei of LNCaP cells.  These conjugates were also 
found to bind the ARE sequence-specifically and with high affinity.  Preliminary 
inhibition results show only modest inhibition with the polyamide-fluorescein 
compounds.  However, higher concentrations and/or treatment with multiple compounds 
may show increased PSA inhibition activity.  The synthesis of higher-affinity compounds 
that target the same DNA sequence in the ARE would also likely effect higher 
transcription inhibition results. 
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Introduction 
 The androgen receptor (AR) is a ligand-activated transcription factor that is part 
of the steroid hormone receptor superfamily of proteins.1-3  By binding their specific 
receptor proteins, steroid hormones act to coordinate many complex series of events 
involved in the development, differentiation, and physiological response of cells to a 
variety of stimuli.  Upon binding a steroid hormone molecule, due to allosteric 
reorganization receptor proteins become able to bind short (~20 bp) cis-acting hormone 
receptor elements (HRE).4  AR action is initiated upon binding of testosterone (T) and, 
especially, 5α-dihydrotestosterone (DHT).  The AR regulates gene expression upon 
binding to androgen-response elements (ARE) located in the 5’ flanking region of 
androgen target genes. 
 Many genes are regulated through ARE domains, including some found in 
kidney, liver, and especially prostate tissue.  Chief among the latter is the prostate 
specific antigen (PSA), which is frequently used as a marker for the diagnosis of prostate 
cancer.  The androgen receptor, like the similar glucocorticoid and progesterone 
receptors, binds its response element as homodimers.5  The study of AR-regulated genes 
has produced a consensus ARE sequence: 5’-GGWACAnnnTGTTCT-3’, along with 
other related nonconsensus sequences.  The PSA ARE domain is a nonconsensus 5’-
AGAACAgcaAGTGCT-3’ sequence.6    From crystal structure studies, it was shown that 
the capitalized hexamer sequences are key to the interaction of the AR with its DNA 
binding site (Figure 5.1).7,8  Though the protein interacts mainly with the major groove, 
each unit of the homodimer injects a lysine residue into the minor groove.  Based on the 
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structural and biochemical data, polyamides were synthesized and tested for their ability 
to inhibit the binding of AR to ARE. 
 
Results 
 Polyamides 1-3 were synthesized based on their projected ability to bind the PSA 
ARE domains (Figure 5.2).  These compounds were sent to Dr. Zhengxin Wang at the 
M.D. Anderson Cancer Center at the University of Texas Southwestern for testing as 
inhibitors of AR-ARE interaction.  Gel mobility shift assays9 showed promising results, 
with compounds 1 and 2 showing complete inhibition of mobility at concentrations ≤ 1 
Figure 5.1  Androgen receptor binding DNA.  The two homodimeric AR chains bind 
the consecutive hexameric half-site direct repeat 5’-ACAAGA-3’ units utilizing 
mainly major groove contacts (blue-green helices lying in the major grooves).  Each 
AR molecule projects a lysine (yellow) into the minor groove.8 
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nM.  Compound 3 also inhibits AR-ARE interaction, but at higher concentrations (≥ 4 
nM).  Based on these positive results, the compounds were tested in DNase I footprinting 
titration assays using a plasmid containing the PSA promoter (Figure 5.3).  These 
compounds were then tested in an in vitro transcription assay using a DNA construct 
containing a luciferase gene under transcriptional control of a PSA ARE.  The 
polyamides 1-3 also showed strong inhibition in this system (Figure 5.4).   
Figure 5.2  Compounds for AR inhibition.  (a) Chemical structures and ball-and-stick 
models of compounds 1-3.  (b) Putative binding sites for 1-3 on the PSA ARE (in 
boldface). 
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Figure 5.4  DNase I Footprinting of 1-3.  (a) PSA promoter PCR fragment used for 
footprinting, bearing the ARE.  (b) Footprinting gels and isotherms for compounds 1-
3. 
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Figure 5.4  In vitro transcription assay for the inhibition of AR action by polyamides 
1-3.  (a) The dose response curves for polyamides 1-3 are depicted showing luciferase 
activity as a function of polyamide concentration.  Polyamide 2 shows a markedly 
lower IC50 than the other polyamides (0.2 pM, blue line.)  Polyamide 1 reaches IC50 at 
2 pM (red line).  Polyamide 3 is much less potent, reaching IC50 at 25 pM (violet line). 
(b) Summary of DNA-binding and AR-inhibition characteristics of polyamides 1-3. 
Though there is < 5-fold difference in binding affinity between 2 and 3, there is a > 
100-fold increase in AR inhibition, showing that polyamide position is a critical 
variable in successful inhibition of transcription. 
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 In attempts to inhibit the AR-ARE interaction in vivo, transient transfection assays 
were performed in LNCaP and PC3 prostate cancer cell lines using an ARE-containing 
luciferase reporter.  PC3 cells do not contain endogenous AR, so one may probe the 
activity of AR with precision by adding controlled amounts of AR.  However, this also 
means that one cannot study the inhibition of an endogenous PSA gene via the polyamide 
binding of ARE.  LNCaP cells contain AR and the PSA gene is actively transcribed in the 
cell.  The advantage LNCaP cells provide is the ability to study the effect of polyamides 
inhibiting an endogenous gene through ARE binding by performing Western blots or RT-
PCR experiments to analyze gene products (either protein or mRNA, respectively.)  
Unfortunately, all attempts to use polyamides 1-3 to inhibit gene expression in vivo failed 
to produce any positive results. 
 Speculating that the negative results were due to the inability of polyamides to 
localize to genomic DNA, either by exclusion from the cell or sequestration in 
cytoplasmic vesicles, polyamide conjugates were synthesized to promote uptake into live 
LNCaP and PC3 nuclei.  The first such compounds synthesized were conjugates of 
polyamides with DHT (4-9, Figure 5.5).  The synthesis of a representative polyamide-
DHT conjugate is shown in Figure 5.6.  These were designed to take advantage both of 
the recognition of steroid hormones by cell membrane transport proteins, to bring the 
polyamides in to the cell, and the DHT-recognition and nuclear transport properties of 
AR, to transmit the polyamides into the cell nucleus (Figure 5.7).10-12  Compounds 4-7 
were based on polyamides 1 and 2, which showed the strongest inhibition in vitro.  They 
incorporate the DHT moiety, linked by a short polyethylene glycol (PEG) domain, in two 
different positions on the polyamide, the tail and the N-methyl position of an internal 
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pyrrole residue.  Compounds 8 and 9 are based on a double pairing-rule mismatch 
polyamide of both 1 and 2, incorporating the DHT moiety as 4-7. 
Figure 5.5  Polyamide-DHT conjugates for AR inhibition.  Chemical structures and 
ball-and-stick models of compounds 4-9. 
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Figure 5.6  Synthesis of polyamide-DHT conjugates.  (i) benzyl bromide, K2CO3, 
H2O.  (ii) t-butylbromoacetate, NaH, DMF, 0ºC.  (iii) Pd/C (10% wt/wt), H2, MeOH, 
AcOH.  (iv) 15, NEt3, CH2Cl2, 60ºC.  (v) 50% (v/v) TFA/CH2Cl2, 1hr at room 
temperature.  (vi) 16, DCC, HOBt, DIEA, DMF.  (vii) 20% TFA/CH2Cl2, 1hr at room 
temperature.  (viii) p-nitrophenylchloroformate (14), NEt3, CH2Cl2. 
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 In order to test the effect on DNA-binding of conjugating the DHT-linker moiety 
to a polyamide, conjugates 4 and 5 were footprinted on the same PSA-ARE PCR 
fragment as 1-3 (Figure 5.8a).  Overall the addition of the DHT-linker moiety reduces the 
affinity of the polyamide for its match site ~10-fold with reference to the parent 
polyamide 1.  Attachment off of the tail also erodes the ability of the compound to 
differentiate between DNA sites, lowering its specificity.  Attachment off of the N-methyl 
position of an internal pyrrole does not have the same negative effect on DNA specificity. 
 Compounds 4-9 were used in a transient transfection assay in PC3 cells, which 
lack endogenous AR.  The cells were treated with AR and 1µM DHT-polyamides.  The 
effect on transcription of a luciferase gene under control of ARE sites was measured by 
luciferase activity (Figure 5.8b).  Conjugate 4 was the most effective, showing ~45% 
reduction in luciferase activity.  Compound 5, also based on polyamide 1, was less 
T or DHT
AR
AR
Target geneARE
AR
Nucleus
Cytoplasm
Figure 5.7  Mechanism of androgen-initiated AR-mediated transcription activation. 
Androgen, here T or DHT, passes through the cytoplasmic membrane either through 
diffusion or active transport.  In the cytoplasm it binds AR, which translocates to the 
nucleus.  Upon recognition of the ARE site, androgen-AR complex (along with other 
chaperone proteins) binds ARE stimulating transcription of the target gene. 
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effective, showing 25% reduction.  The only other conjugate to show a significant effect 
was 6, based on polyamide 2, which showed ~20% reduction in luciferase.  The higher 
level of inhibition of 4 and 5 over 6 and 7 is somewhat surprising, since the in vitro 
results suggested compounds based on polyamide 2 should be the most efficient 
inhibitors.  This may be a result of higher nuclear transport of 4 and 5 over 6 and 7. 
Figure 5.8  DNA-binding and transcription inhibition characteristics of DHT 
conjugates.  (a) DNase I footprinting gels and isotherms for 4 and 5.  (b) Inhibition of 
luciferase transcription was greatest for compound 4, at ~45% reduction (activity 
normalized to +AR –PA sample.  Key: column 1: –AR, -PA; column 2: +AR, -PA; 
column 3: +AR, 1 µM 4; column 4: +AR, 1 µM 5; column 5: +AR, 1 µM 6; column 6:
+AR, 1 µM 7; column 7: +AR, 1 µM 8; column 8: +AR, 1 µM 9. 
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 After it was determined that polyamide-fluorescein conjugates tended to possess 
favorable uptake qualities (see Chapter 4), fluorescein derivatives 17-19 were prepared 
(Figure 5.9a).  These compounds were designed based on polyamides 1 and 2, as well as 
a double pairing-rule mismatch with reference to 1 and 2.  After verification that they 
stained the nuclei of PC3 and LNCaP cells, the conjugates were used in the same 
transient transfection assay that was used on compounds 4-9 (Figure 5.9b).  Compound 
17 seemed to show some inhibition at 0.1 µM.  However, compound 18 did not show any 
significant inhibition.  As expected, mismatch compound 19 also produced no inhibitory 
effect.  Since it was shown that these three compounds all enter cell nuclei, it is surprising 
that the compounds were less efficient than even the DHT conjugates at inhibiting 
transcription.  It may be that the DNA-binding affinities of 17 and 18 are low enough that 
higher concentrations (> 1µM) are needed.  Also, a combination of treatment with both 
17 and 18 might provide greater inhibition than either one alone could, in a synergistic 
fashion. 
 
Outlook and Future Directions 
 The success in creating DNA-binding polyamides with the ability to cross the 
cytoplasmic membrane and localize to genomic DNA provides the basis for undertaking 
many in vivo transcription regulation projects.  In the case of AR-ARE inhibition, the in 
vivo experiments performed to date have all been on model systems transiently 
transfected into cells.  However, the ultimate goal of transfection experiments with DNA-
binding polyamides is the inhibition of endogenous genes upon polyamide treatment.  To 
this end it would be interesting to treat cells that actively transcribe the PSA gene under  
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Figure 5.6  Polyamide-FITC conjugates for AR-ARE inhibition.  (a) Chemical 
structures and ball-and-stick models for 17-19.  (b) Transient transfection luciferase 
inhibition assay.  Compound 17 seems to have some small effect on luciferase 
transcription, though strangely not at the highest concentration (1 µM, column 3, 
compare to column 2).  Compounds 18 and 19 show no significant effect.  The light 
blue portion of the bars is luciferase activity, in arbitrary units.  The dark blue portion 
is ½ of the standard deviation after three replicate experiments. 
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control of AR, such as LNCaP cells, and assay for changes in the level of gene products, 
either protein (Western blot) or mRNA (RT-PCR).  The development of new aromatic 
heterocycles that can take part in DNA recognition will permit the targeting of DNA 
sequences in a more general manner.  By combining new polyamides based on the lead 
compounds 1 and 2, with uptake vectors such as FITC, and by assaying their effects on 
endogenous PSA production by RT-PCR, it seems likely that a path to successful gene 
inhibition in living cells by polyamides will be illuminated. 
 
Experimental 
Chemicals 
Polyamides were synthesized by solid phase methods on Boc-β-ala-PAM resin 
(Peptides International, Louisville, KY)13 or on Kaiser oxime resin (Nova Biochem, 
Laufelfingen, Switzerland).14 All fluorescent dye reagents were from Molecular Probes. 
Chemicals not otherwise specified were from Sigma-Aldrich. 
 
Synthesis of Polyamide-DHT Conjugates 
2-(N,N-Dibenzyl-2-aminoethoxy)ethanol (10)15 
 2-(2-aminoethoxy)ethanol (15 mL, 150 mmol), potassium carbonate (41.5 g, 300 
mmol), and 45 mL water were added to a 250 mL round bottom flask equipped with a 
magnetic stirrer and a dropping funnel.  Benzyl bromide (35.7 mL, 300 mmol) was added 
dropwise over 1 hr.  The solution was then stirred overnight at room temperature.  Et2O 
(250 mL) was added to the mixture, separated, and the aqueous layer was washed with a 
further 50 mL Et2O.  The combined organic portions were washed with 300 mL brine and 
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150 mL water, then dried with MgSO4 and concentrated to yield a clear oil.  This was 
purified on a short column of silica with 5:1 hexanes:EtOAc→100% EtOAc to yield a 
clear oil (22 g, 52% yield).  1H-NMR (CDCl3) δ 7.20-7.38 (m, 10 H), 3.65 (s, 4 H), 3.58 
(t, 2 H), 3.47 (t, 2 H), 2.69 (t, 2 H), 2.39 (s, 1 H). 
N,N-Dibenzyl-8-amino-3,6-dioxaoctanoic acid t-butyl ester (11)16 
NaH (1.33 g of 95% wt/wt, 50 mmol) was added to a flask under argon with 100 
mL DMF.  Compound 10 (10 g, 35 mmol) was added and the mixture stirred at room 
temperature for 2 hrs.  t-Butylbromoacetate was added to a dry flask under Ar at 0ºC.  
Solution from above was added via cannula and stirred at 0ºC for 30 min.  The resulting 
solution was then allowed to warm to room temperature and stir overnight.  10 mL 
saturated NH4Cl was added and the solution was concentrated to remove DMF.  The 
remainder was partitioned between 100 mL sat. NH4Cl and 150 mL EtOAc.  The organic 
layer was washed with 100 mL NH4Cl, 100 mL NaHCO3 (1M), and 100 mL brine, then 
dried with MgSO4 and concentrated to yield an amber oil.  Purification on silica with 5:1 
hexanes:EtOAc provided 9.5 g (68% yield) clear oil.  1H-NMR (CDCl3) δ 7.19-7.38 (m, 
10 H), 3.94 (s, 1 H), 3.40-3.60 (m, 10 H), 2.69 (t, 2 H), 1.38 (s, 9 H). 
8-amino-3,6-dioxaoctanoic acid t-butyl ester (12) 
 Compound 11 (6.4 g, 16 mmol) was dissolved in a solution of 750 µL AcOH in 
150 mL MeOH.  Palladium on charcoal (10% wt/wt) was added and the mixture was 
sealed in a Parr bomb and pressurized to ~7 atm H2.  The solution was stirred at room 
temperature for 18 hrs, then filtered through celite to remove Pd/C.  The filtrate was 
concentrated to yield an amber oil, which was dissolved in 30 mL CH2Cl2 and washed 
 171
with 1M NaHCO3 (20 mL) and concentrated.  1H-NMR (CDCl3) δ 4.24 (s, 2 H), 3.94 (t, 
2 H), 3.71 (s, 4 H), 3.07 (t, 2 H), 1.45 (s, 9 H). 
5α-dihydrotestosterone-N-(8-amino-3,6-dioxaoctanoic acid) carbamate (13) 
 12 (0.33 g, 1.5 mmol) and 15 (0.46 g, 1 mmol) were dissolved in 1 mL CH3CN 
and DIEA (175 mL, 1 mmol) and stirred at 60°C for 24 hrs.  The mixture was 
concentrated, suspended in 10 mL CH2Cl2 and washed with 2 x 20 mL 10% (wt/wt) citric 
acid and 20 mL water.  The organic layer was dried over MgSO4 and concentrated to 
yield a brown oil.  This was treated with TFA (50% in CH2Cl2, 10 mL total volume, 2 hrs 
at room temperature) and concentrated to yield a brown oil.  The crude product was run 
through a short column of silica with 2:1 hexanes:EtOAc, then eluted with MeOH and 
concentrated to an oily brown solid.  Recrystallization from EtOH/water, resuspension in 
DCM, and concentration provided 13 as a light tan foam (0.154 g, 29% yield). 
5α-dihydrotestosterone-4-nitrophenyl carbonate (15) 
 5α-dihydrotestosterone (2.0 g, 6.9 mmol) was dissolved in 40 mL CH2Cl2.  p-
nitrophenyl chloroformate (14) (1.7 g, 8.3 mmol) and triethylamine (1.15 mL, 8.3 mmol) 
were then added and the resulting solution was stirred at 35ºC for 12 hrs.  The solution 
was concentrated, resuspended in 50 mL CH2Cl2, washed with 40 mL 1M NaHCO3, 40 
mL 10% (wt/wt) citric acid, and 40 mL brine.  The organic portion was dried over 
MgSO4 and concentrated to yield 2.83 g 15 (91% yield) as a fluffy white solid.  1H-NMR 
(CDCl3) δ 3.99 (s, 2 H), 3.65 (m, 4 H), 3.55 (t, 2 H), 3.33 (t, 2 H), 2.45-0.75 (series of m, 
29 H), 1.47 (s, 9 H). 
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DHT-polyamides 4-9 
 13 (4.8 mg, 10 µmol) was activated as the –OBt ester with DCC (10 µmol) and 
HOBt (10 µmol) in DMF (60 µL) for 30 min at room temperatue.  This was added to a 
solution of polyamide (each as 16, possessing a free amine in the appropriate position and 
a t-Boc-protected (R) H2Nγ−turn, 2 µmol) and DIEA (1 µL, 6 µmol) in 50 µL DMF and 
the resulting reaction allowed to react for 1 hr at room temperature.  Dp (2.5 µL) was 
added to quench remaining activated acid and the solution was concentrated to a brown 
oil in a speedvac.  This was treated with 80% (v/v) TFA/CH2Cl2 for 2 hrs at room 
temperature, purified by C18 reverse-phase preparatory HPLC, and lyophilized to provide 
4-9 as white powders.  Characterization:  4, MALDI-TOF [M+H]+ (monoisotopic mass) 
calcd 1670.9, obsd 1671.0;  5, MALDI-TOF [M+H]+ (monoisotopic mass) calcd 1643.8, 
obsd 1643.9; 6, MALDI-TOF [M+H]+ (monoisotopic mass) calcd 1671.9, obsd 1672.0; 
7, MALDI-TOF [M+H]+ (monoisotopic mass) calcd 1742.9, obsd 1743.1; 8, MALDI-
TOF [M+H]+ (monoisotopic mass) calcd 1671.9, obsd 1672.0; 9, MALDI-TOF [M+H]+ 
(monoisotopic mass) calcd 1742.9, obsd 1743.0. 
FITC-polyamides 17-19 
 Polyamides were synthesized on Kaiser oxime resin as previously detailed, each 
possessing a chiral (R) H2Nγ−turn protected as the t-butyl carbamate.  Each polyamide (2 
µmol) was dissolved in 100 µL DMF and 10 µL DIEA.  Fluorescein isothiocyanate (3 
µmol) was added and the reactions allowed to proceed in the dark at room temperature 
for 1 hr.  The polyamides were precipitated by addition of Et2O and treated with 100 µL 
20% (v/v) TFA/CH2Cl2 for 1 hr at room temperature.  The solutions were then 
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concentrated, suspended in 10 mL 0.1% (v/v) TFA/water, purified by C18 reverse-phase 
preparatory HPLC, and lyophilized to provide 17-19 as orange powders. 
 
Gel Mobility Shift Assays  
Gel shift assays were performed by Dr. Zhengxin Wang at the M.D. Anderson 
Cancer Center at the University of Texas Southwestern. 
 
In vitro Transcription Reactions  
In vitro transcription reactions were performed by Dr. Zhengxin Wang at the 
M.D. Anderson Cancer Center at the University of Texas Southwestern. 
 
Transient Transfection Assays 
 Transient transfection assays were performed by Dr. Zhengxin Wang at the M.D. 
Anderson Cancer Center at the University of Texas Southwestern.  Briefly, the human 
prostate cancer cell lines PC3 and LNCaP were cultured in a 5% CO2 atmosphere at 37°C 
in RPMI medium 1640 supplemented with 10% fetal bovine serum (Irvine Scientific) and 
1% penicillin/streptomycin solution (Sigma).  The report vector was pGL3-ARE, 
containing 4 ARE’s and the E4 core promoter fused to the luciferase gene.  The 
expression vector is pcDNA-AR containing human AR under control of the CMV 
promoter.  Assays were performed on 0.25 million cells, using 500 µg pcDNA-AR, 500 
µg pGL3-ARE, 20 µg pRL-LUC as an internal control, and 10 µL LipofectAmine 
(Invitrogen).  After 48 hrs, the cells were harvested for luciferase assay. 
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DNase I Footprinting Titrations 
A 217 bp 5’ 32P-labeled PCR fragment was generated from template plasmid 
pPSA-ARE in accordance with standard protocols and isolated by nondenaturing gel 
electrophoresis.17  All DNase I footprinting reactions were carried out in a volume of 400 
µL.  A polyamide stock solution or water (for reference lanes) was added to TKMC 
buffer, with final concentrations of 50 mM Tris-HCl, 50 mM KCl, 50 mM MgCl2, and 25 
mM CaCl2, pH 7.0, and 15 kcpm 5’-radiolabeled DNA.  The solutions were equilibrated 
for 12-18 h at 22°C.  Cleavage was initiated by the addition of 10 µL of a DNase I stock 
solution and was allowed to proceed for 7 min at 22°C.  The reactions were stopped by 
adding 50 µL of a solution containing 2.25 M NaCl, 150 mM EDTA, 0.6 mg/mL 
glycogen, and 30 µM base pair calf thymus DNA and then ethanol precipitated.   The 
cleavage products were resuspended in 100 mM Trisborate-EDTA/80% formamide 
loading buffer, denatured at 85°C for 10 min, and immediately loaded onto an 8% 
denaturing polyacrylamide gel (5% cross-link, 7 M urea) at 2000 V for 2 h and 15 min.   
The gels were dried under vacuum at 80 °C and quantitated using storage phosphor 
technology. 
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